: The AMEDEO Literature Guide

Home The Word Brain

My Amedeo

FAQ

Privacy

About

Flying Publisher

The Angels Initiative

Stroke prevention

Influenza

Free Subscription

Articles published in J Infect Dis
Retrieve available abstracts of 536 articles:
HTML format

Single Articles

July 2022

BRITTO C, Mohorianu I, Yeung T, Cheung E, et al
Host respiratory transcriptome signature associated with poor outcome in children with influenza-Staphylococcus aureus pneumonia.
J Infect Dis. 2022 Jul 28. pii: 6650994. doi: 10.1093.
PubMed Abstract available

WAGNER AL, Sanchez N, Kubale J, Kuan G, et al
Single dose vaccination among infants and toddlers provides modest protection against influenza illness which wanes after 5 months.
J Infect Dis. 2022 Jul 7. pii: 6633354. doi: 10.1093.
PubMed Abstract available

June 2022

TEMPLE DS, Hegarty-Craver M, Furberg RD, Preble EA, et al
Wearable sensor-based detection of influenza in presymptomatic and asymptomatic individuals.
J Infect Dis. 2022 Jun 27. pii: 6618641. doi: 10.1093.
PubMed Abstract available

ACOSTA-AMPUDIA Y, Monsalve DM, Rojas M, Rodriguez Y, et al
Persistent Autoimmune Activation and Proinflammatory State in Post-Coronavirus Disease 2019 Syndrome.
J Infect Dis. 2022;225:2155-2162.
PubMed Abstract available

VEDHARA K, Ayling K, Jia R, Fairclough L, et al
Relationship Between Anxiety, Depression, and Susceptibility to Severe Acute Respiratory Syndrome Coronavirus 2 Infection: Proof of Concept.
J Infect Dis. 2022;225:2137-2141.
PubMed Abstract available

TURNBULL J, Jha RR, Ortori CA, Lunt E, et al
Serum Levels of Proinflammatory Lipid Mediators and Specialized Proresolving Molecules Are Increased in Patients With Severe Acute Respiratory Syndrome Coronavirus 2 and Correlate With Markers of the Adaptive Immune Response.
J Infect Dis. 2022;225:2142-2154.
PubMed Abstract available

CHANG YH, Kao CC, Fang JJ, Lee YH, et al
Correspondence to Morbidity and Mortality Among Adults Experiencing Homelessness Hospitalized With Coronavirus Disease 2019.
J Infect Dis. 2022;225:2235.
PubMed

DEVINCENZO J, Cass L, Murray A, Woodward K, et al
Safety and Antiviral Effects of Nebulized PC786 in a Respiratory Syncytial Virus Challenge Study.
J Infect Dis. 2022;225:2087-2096.
PubMed Abstract available

NYAWANDA BO, Otieno NA, Otieno MO, Emukule GO, et al
The Impact of Maternal Human Immunodeficiency Virus Infection on the Burden of Respiratory Syncytial Virus Among Pregnant Women and Their Infants, Western Kenya.
J Infect Dis. 2022;225:2097-2105.
PubMed Abstract available

LAURIE MT, Liu J, Sunshine S, Peng J, et al
SARS-CoV-2 Variant Exposures Elicit Antibody Responses With Differential Cross-Neutralization of Established and Emerging Strains Including Delta and Omicron.
J Infect Dis. 2022;225:1909-1914.
PubMed Abstract available

May 2022

HAYDEN FG, Lenk RP, Stonis L, Oldham-Creamer C, et al
Favipiravir Treatment of Uncomplicated Influenza in Adults: Results of Two Phase 3, Randomized, Double-Blind, Placebo-Controlled Trials.
J Infect Dis. 2022 May 26. pii: 6568151. doi: 10.1093.
PubMed Abstract available

MONDELLI MU
Antibodies: A Double Leg Takedown Against COVID-19.
J Infect Dis. 2022;225:1685-1687.
PubMed

PATI A, Nayak N, Sarangi S, Barik D, et al
CCL5 rs2107538 Variant Is Associated With Protection Against SARS-CoV-2 Infection and Related Mortality: A Population-Based Study.
J Infect Dis. 2022;225:1865-1866.
PubMed

PEREZ-GARCIA F, Martin-Vicente M, Bermejo-Martin JF, Resino S, et al
Reply to Pati et al.
J Infect Dis. 2022;225:1866-1868.
PubMed

HAN T, Park H, Jeong Y, Lee J, et al
COVID-19 Cluster Linked to Aerosol Transmission of SARS-CoV-2 via Floor Drains.
J Infect Dis. 2022;225:1554-1560.
PubMed Abstract available

BAHL P, Doolan C, de Silva C, Chughtai AA, et al
Airborne or Droplet Precautions for Health Workers Treating Coronavirus Disease 2019?
J Infect Dis. 2022;225:1561-1568.
PubMed Abstract available

April 2022

OKUDA M, Sakai-Tagawa Y, Koga M, Koibuchi T, et al
Immunological correlates of prevention of the onset of seasonal H3N2 influenza.
J Infect Dis. 2022 Apr 27. pii: 6574940. doi: 10.1093.
PubMed Abstract available

REYES J, Stiehl B, Delgado J, Kinzel M, et al
Human Research Study of Particulate Propagation Distance From Human Respiratory Function.
J Infect Dis. 2022;225:1321-1329.
PubMed Abstract available

IVERSEN KK, Afzal S, Ahlstrom MG, Nordestgaard BG, et al
Lung Function Decline in Relation to COVID-19 in the General Population: A Matched Cohort Study With Prepandemic Assessment of Lung Function.
J Infect Dis. 2022;225:1308-1316.
PubMed Abstract available

AULD SC
Lung Function After Coronavirus Disease 2019: Some Answers, More Questions.
J Infect Dis. 2022;225:1305-1307.
PubMed

CHANG YH, Liaw YP
Correspondence to Maternal-Fetal Immunologic Response to SARS-CoV-2 Infection in a Symptomatic Vulnerable Population: A Prospective Cohort.
J Infect Dis. 2022;225:1494.
PubMed

XIONG W, Tsang TK, Perera RAPM, Leung NHL, et al
Biphasic waning of hemagglutination inhibition antibody titers after influenza vaccination in children.
J Infect Dis. 2022 Apr 5. pii: 6563665. doi: 10.1093.
PubMed Abstract available

LEMIEUX JE, Luban J
Consulting the Oracle of SARS-CoV-2 Infection.
J Infect Dis. 2022;225:1115-1117.
PubMed

NUSSENBLATT V, Roder AE, Das S, de Wit E, et al
Yearlong COVID-19 Infection Reveals Within-Host Evolution of SARS-CoV-2 in a Patient With B-Cell Depletion.
J Infect Dis. 2022;225:1118-1123.
PubMed Abstract available

KOIVISTO K, Nieminen T, Mejias A, Capella Gonzalez C, et al
Respiratory Syncytial Virus (RSV)-Specific Antibodies in Pregnant Women and Subsequent Risk of RSV Hospitalization in Young Infants.
J Infect Dis. 2022;225:1189-1196.
PubMed Abstract available

FERGIE J, Suh M, Jiang X, Fryzek JP, et al
Respiratory Syncytial Virus and All-Cause Bronchiolitis Hospitalizations Among Preterm Infants Using the Pediatric Health Information System (PHIS).
J Infect Dis. 2022;225:1197-1204.
PubMed Abstract available

March 2022

RIEKE GJ, van Bremen K, Bischoff J, To Vinh M, et al
Induction of NK cell-mediated antibody-dependent cellular cytotoxicity (ADCC) against SARS-CoV-2 after natural infection is more potent than after vaccination.
J Infect Dis. 2022 Mar 22. pii: 6552258. doi: 10.1093.
PubMed Abstract available

PEREZ-GARCIA F, Martin-Vicente M, Rojas-Garcia RL, Castilla-Garcia L, et al
High SARS-CoV-2 Viral Load and Low CCL5 Expression Levels in the Upper Respiratory Tract Are Associated With COVID-19 Severity.
J Infect Dis. 2022;225:977-982.
PubMed Abstract available

LI Y, Wang X, Cong B, Deng S, et al
Understanding the Potential Drivers for Respiratory Syncytial Virus Rebound During the Coronavirus Disease 2019 Pandemic.
J Infect Dis. 2022;225:957-964.
PubMed Abstract available

LYSKI ZL, Brunton AE, Strnad MI, Sullivan PE, et al
Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)-Specific Memory B Cells From Individuals With Diverse Disease Severities Recognize SARS-CoV-2 Variants of Concern.
J Infect Dis. 2022;225:947-956.
PubMed Abstract available

NGUYEN D, Xiao J, Simmonds P, Lamikanra A, et al
Effects of Severe Acute Respiratory Syndrome Coronavirus 2 Strain Variation on Virus Neutralization Titers: Therapeutic Use of Convalescent Plasma.
J Infect Dis. 2022;225:971-976.
PubMed Abstract available

DIEZ JM, Romero C, Cruz M, Vandeberg P, et al
Anti-Severe Acute Respiratory Syndrome Coronavirus 2 Hyperimmune Immunoglobulin Demonstrates Potent Neutralization and Antibody-Dependent Cellular Cytotoxicity and Phagocytosis Through N and S Proteins.
J Infect Dis. 2022;225:938-946.
PubMed Abstract available

ROHRIG A, Eyal N
The Ethics of Human Challenge Trials Using Emerging Severe Acute Respiratory Syndrome 2 Variants.
J Infect Dis. 2022;225:934-937.
PubMed Abstract available

CUNNINGHAM JL, Virhammar J, Ronnberg B, Dopico XC, et al
Antibody Responses to Severe Acute Respiratory Syndrome Coronavirus 2 in the Serum and Cerebrospinal Fluid of Patients With Coronavirus Disease 2019 and Neurological Symptoms.
J Infect Dis. 2022;225:965-970.
PubMed Abstract available

MCLAUGHLIN JM, Khan F, Schmitt HJ, Agosti Y, et al
Respiratory Syncytial Virus-Associated Hospitalization Rates among US Infants: A Systematic Review and Meta-Analysis.
J Infect Dis. 2022;225:1100-1111.
PubMed Abstract available

DEBIASI RL
Severe Acute Respiratory Syndrome-Coronavirus-2 Effects at the Maternal-Fetal Interface.
J Infect Dis. 2022;225:745-747.
PubMed

SHOOK LL, Brigida S, Regan J, Flynn JP, et al
SARS-CoV-2 Placentitis Associated With B.1.617.2 (Delta) Variant and Fetal Distress or Demise.
J Infect Dis. 2022;225:754-758.
PubMed Abstract available

REGAN AK, Arah OA, Fell DB, Sullivan SG, et al
SARS-CoV-2 Infection During Pregnancy and Associated Perinatal Health Outcomes: A National US Cohort Study.
J Infect Dis. 2022;225:759-767.
PubMed Abstract available

WELCH JL, Xiang J, Chang Q, Houtman JCD, et al
T-Cell Expression of Angiotensin-Converting Enzyme 2 and Binding of Severe Acute Respiratory Coronavirus 2.
J Infect Dis. 2022;225:810-819.
PubMed Abstract available

LARCADE R, DeShea L, Lang GA, Caballero MT, et al
Maternal-Fetal Immunologic Response to SARS-CoV-2 Infection in a Symptomatic Vulnerable Population: A Prospective Cohort.
J Infect Dis. 2022;225:800-809.
PubMed Abstract available

HWANG H, Lim JS, Song SA, Achangwa C, et al
Transmission Dynamics of the Delta Variant of SARS-CoV-2 Infections in South Korea.
J Infect Dis. 2022;225:793-799.
PubMed Abstract available

KOTWA JD, Jamal AJ, Mbareche H, Yip L, et al
Surface and Air Contamination With Severe Acute Respiratory Syndrome Coronavirus 2 From Hospitalized Coronavirus Disease 2019 Patients in Toronto, Canada, March-May 2020.
J Infect Dis. 2022;225:768-776.
PubMed Abstract available

PULVIRENTI F, Milito C, Cinetto F, Fernandez Salinas A, et al
Severe Acute Respiratory Syndrome Coronavirus 2 Monoclonal Antibody Combination Therapy in Patients With Coronavirus Disease 2019 and Primary Antibody Deficiency.
J Infect Dis. 2022;225:820-824.
PubMed Abstract available

DIAZ-DIAZ A, Bunsow E, Garcia-Maurino C, Moore-Clingenpeel M, et al
Nasopharyngeal Codetection of Haemophilus influenzae and Streptococcus pneumoniae Shapes Respiratory Syncytial Virus Disease Outcomes in Children.
J Infect Dis. 2022;225:912-923.
PubMed Abstract available

February 2022

MORITZKY SA, Richards KA, Glover MA, Krammer F, et al
The negative effect of pre-existing immunity on influenza vaccine responses transcends the impact of vaccine formulation type and vaccination history.
J Infect Dis. 2022 Feb 24. pii: 6535476. doi: 10.1093.
PubMed Abstract available

ROACH M, Hiatt RA, Black S
Commentary: Race, COVID-19 and Nursing Homes.
J Infect Dis. 2022;225:555-556.
PubMed

LORCA-ORO C, Vila J, Pleguezuelos P, Vergara-Alert J, et al
Rapid SARS-CoV-2 Inactivation in a Simulated Hospital Room Using a Mobile and Autonomous Robot Emitting Ultraviolet-C Light.
J Infect Dis. 2022;225:587-592.
PubMed Abstract available

MONTAGUE BT, Wipperman MF, Hooper AT, Hamon SC, et al
Anti-SARS-CoV-2 IgA Identifies Asymptomatic Infection in First Responders.
J Infect Dis. 2022;225:578-586.
PubMed Abstract available

ELHARAKE JA, Shafiq M, McFadden SM, Malik AA, et al
The Association of Coronavirus Disease 2019 Risk Perception, County Death Rates, and Voluntary Health Behaviors Among United States Adult Population.
J Infect Dis. 2022;225:593-597.
PubMed Abstract available

RYAN KA, Schewe KE, Crowe J, Fotheringham SA, et al
Sequential Delivery of Live Attenuated Influenza Vaccine and Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) in the Ferret Model Can Reduce SARS-CoV-2 Shedding and Does Not Result in Enhanced Lung Pathology.
J Infect Dis. 2022;225:404-412.
PubMed Abstract available

OCHOA V, Diaz FE, Ramirez E, Fentini MC, et al
Infants Younger Than 6 Months Infected With SARS-CoV-2 Show the Highest Respiratory Viral Loads.
J Infect Dis. 2022;225:392-395.
PubMed Abstract available

LEBREIL AL, Greux V, Glenet M, Huguenin A, et al
Surfaces and Air Contamination by Severe Acute Respiratory Syndrome Coronavirus 2 Using High-Flow Nasal Oxygenation or Assisted Mechanical Ventilation in Intensive Care Unit Rooms of Patients With Coronavirus Disease 2019.
J Infect Dis. 2022;225:385-391.
PubMed Abstract available

KLEIN J, Brito AF, Trubin P, Lu P, et al
Longitudinal Immune Profiling of a Severe Acute Respiratory Syndrome Coronavirus 2 Reinfection in a Solid Organ Transplant Recipient.
J Infect Dis. 2022;225:374-384.
PubMed Abstract available

CHAMBERLAIN AT, Toomey KE, Bradley H, Hall EW, et al
Cumulative Incidence of SARS-CoV-2 Infections Among Adults in Georgia, United States, August to December 2020.
J Infect Dis. 2022;225:396-403.
PubMed Abstract available

MALENFANT JH, Eslami M, Dao BL, Moore L, et al
Seroprevalence of Severe Acute Respiratory Syndrome Coronavirus 2 Among Skilled Nursing Facility Residents and Staff Members-Los Angeles County, August-September 2020.
J Infect Dis. 2022;225:367-373.
PubMed Abstract available

January 2022

KRAYNYAK KA, Blackwood E, Agnes J, Tebas P, et al
SARS-CoV-2 DNA Vaccine INO-4800 Induces Durable Immune Responses Capable of Being Boosted in a Phase 1 Open-Label Trial.
J Infect Dis. 2022 Jan 25. pii: 6515374. doi: 10.1093.
PubMed Abstract available

PUING AG, Ho S, Frankel P, Tegtmeier B, et al
Severe Acute Respiratory Syndrome Coronavirus 2-Specific Monoclonal Antibody for the Treatment of Mild to Moderate Coronavirus Disease 2019 in Cancer Patients: A Single-Center Experience.
J Infect Dis. 2022;225:352-354.
PubMed

KASPERSEN KA, Hindhede L, Boldsen JK, Mikkelsen S, et al
Estimation of SARS-CoV-2 Infection Fatality Rate by Age and Comorbidity Status Using Antibody Screening of Blood Donors During the COVID-19 Epidemic in Denmark.
J Infect Dis. 2022;225:219-228.
PubMed Abstract available

STAPLETON EM, Welch JL, Ubeda EA, Xiang J, et al
Urban Particulate Matter Impairment of Airway Surface Liquid-Mediated Coronavirus Inactivation.
J Infect Dis. 2022;225:214-218.
PubMed Abstract available

MERTZ C, Glowinski R, Cohen SH, Mertz S, et al
Severe Acute Respiratory Syndrome Coronavirus 2 RNAemia and Clinical Outcomes in Children With Coronavirus Disease 2019.
J Infect Dis. 2022;225:208-213.
PubMed Abstract available

KOVACEVIC A, Eggo RM, Baguelin M, Domenech de Celles M, et al
The Impact of Cocirculating Pathogens on Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)/Coronavirus Disease 2019 Surveillance: How Concurrent Epidemics May Introduce Bias and Decrease the Observed SARS-CoV-2 Percentage Positivity.
J Infect Dis. 2022;225:199-207.
PubMed Abstract available

BUDER F, Bauswein M, Magnus CL, Audebert F, et al
Contribution of High Viral Loads, Detection of Viral Antigen and Seroconversion to Severe Acute Respiratory Syndrome Coronavirus 2 Infectivity.
J Infect Dis. 2022;225:190-198.
PubMed Abstract available

SHRAGAI T, Smith-Jeffcoat SE, Koh M, Schechter MC, et al
Epidemiologic, Immunologic, and Virus Characteristics in Patients With Paired Severe Acute Respiratory Syndrome Coronavirus 2 Serology and Reverse-Transcription Polymerase Chain Reaction Testing.
J Infect Dis. 2022;225:229-237.
PubMed Abstract available

GUAN M, Johannesen E, Tang CY, Hsu AL, et al
Intrauterine fetal demise in the third trimester of pregnancy associated with mild infection with the SARS-CoV-2 Delta variant without protection from vaccination.
J Infect Dis. 2022 Jan 13. pii: 6506263. doi: 10.1093.
PubMed Abstract available

KRISTENSEN JH, Hasselbalch RB, Pries-Heje M, Nielsen PB, et al
Effect of influenza vaccination on risk of COVID-19 - A prospective cohort study of 46,000 health care workers.
J Infect Dis. 2022 Jan 5. pii: 6497955. doi: 10.1093.
PubMed Abstract available

MEMEL ZN, Lee JJ, Foulkes AS, Chung RT, et al
Association of Statins and 28-Day Mortality Rates in Patients Hospitalized With Severe Acute Respiratory Syndrome Coronavirus 2 Infection.
J Infect Dis. 2022;225:19-29.
PubMed Abstract available

PATEL EU, Bloch EM, Tobian AAR
Severe Acute Respiratory Syndrome Coronavirus 2 Serosurveillance in Blood Donor Populations.
J Infect Dis. 2022;225:1-4.
PubMed

FRANCIS RV, Billam H, Clarke M, Yates C, et al
The Impact of Real-Time Whole-Genome Sequencing in Controlling Healthcare-Associated SARS-CoV-2 Outbreaks.
J Infect Dis. 2022;225:10-18.
PubMed Abstract available

December 2021

LUCZKOWIAK J, Labiod N, Rivas G, Rolo M, et al
Neutralizing response against SARS-CoV-2 variants 8 months after BNT162b2 vaccination in naive and COVID-19 convalescent individuals.
J Infect Dis. 2021 Dec 28. pii: 6486499. doi: 10.1093.
PubMed Abstract available

BRUXVOORT KJ, Ackerson B, Sy LS, Bhavsar A, et al
Recombinant adjuvanted zoster vaccine and reduced risk of COVID-19 diagnosis and hospitalization in older adults.
J Infect Dis. 2021 Dec 28. pii: 6486498. doi: 10.1093.
PubMed Abstract available

ABARA WE, Gee J, Delorey M, Tun Y, et al
Expected Rates of Select Adverse Events following Immunization for COVID-19 Vaccine Safety Monitoring.
J Infect Dis. 2021 Dec 27. pii: 6484617. doi: 10.1093.
PubMed Abstract available

LIU J, Huang B, Li G, Chang X, et al
Immunogenicity and Safety of a Three-Dose Regimen of a SARS-CoV-2 Inactivated Vaccine in Adults: A Randomized, Double-blind, Placebo-controlled Phase 2 Trial.
J Infect Dis. 2021 Dec 27. pii: 6484920. doi: 10.1093.
PubMed Abstract available

KIM SS, Naioti EA, Halasa NB, Stewart LS, et al
Vaccine Effectiveness against Influenza Hospitalization and Emergency Department Visits in Two A(H3N2) Dominant Influenza Seasons among Children <18 Years Old, New Vaccine Surveillance Network 2016-17 and 2017-18.
J Infect Dis. 2021 Dec 24. pii: 6482612. doi: 10.1093.
PubMed Abstract available

FALSEY AR, Walsh EE, Scott DA, Gurtman A, et al
Phase 1/2 Randomized Study of the Immunogenicity, Safety and Tolerability of an RSV Prefusion F Vaccine in Adults With Concomitant Inactivated Influenza Vaccine.
J Infect Dis. 2021 Dec 21. pii: 6472733. doi: 10.1093.
PubMed Abstract available

WALSH EE, Falsey AR, Scott DA, Gurtman A, et al
A Randomized Phase 1/2 Study of a Respiratory Syncytial Virus Prefusion F Vaccine.
J Infect Dis. 2021 Dec 21. pii: 6472747. doi: 10.1093.
PubMed Abstract available

LEWIS NM, Naioti EA, Self WH, Ginde AA, et al
Effectiveness of mRNA vaccines in preventing COVID-19 hospitalization by age and burden of chronic medical conditions among immunocompetent US adults, March-August 2021.
J Infect Dis. 2021 Dec 21. pii: 6472998. doi: 10.1093.
PubMed Abstract available

PHIJFFER EWEM, Bont LJ
Are we ready for maternal RSV vaccination?
J Infect Dis. 2021 Dec 21. pii: 6472740. doi: 10.1093.
PubMed

FAHIM SM, Hossain MS, Sen S, Das S, et al
Nutrition and Food Security in Bangladesh: Achievements, Challenges, and Impact of the COVID-19 Pandemic.
J Infect Dis. 2021;224.
PubMed Abstract available

VERBURGH ML, Boyd A, Wit FWNM, Schim van der Loeff MF, et al
Similar risk of SARS-CoV-2 infection and similar nucleocapsid antibody levels in people with well-controlled HIV and a comparable cohort of people without HIV.
J Infect Dis. 2021 Dec 20. pii: 6470931. doi: 10.1093.
PubMed Abstract available

GERIC C, Saroufim M, Landsman D, Richard J, et al
Impact of Covid-19 on Tuberculosis Prevention and Treatment in Canada: a multicentre analysis of 10,833 patients.
J Infect Dis. 2021 Dec 17. pii: 6469005. doi: 10.1093.
PubMed Abstract available

LU Z, Laing ED, Pena DaMata J, Pohida K, et al
Durability of SARS-CoV-2-Specific T-Cell Responses at 12 Months Postinfection.
J Infect Dis. 2021;224:2010-2019.
PubMed Abstract available

SCHULZE J, Mache C, Balazs A, Frey D, et al
Analysis of Severe Acute Respiratory Syndrome 2 Replication in Explant Cultures of the Human Upper Respiratory Tract Reveals Broad Tissue Tropism of Wild-Type and B.1.1.7 Variant Viruses.
J Infect Dis. 2021;224:2020-2024.
PubMed Abstract available

PATI A, Padhi S, Nayak TKS, Panda AK, et al
Angiotensin-Converting Enzyme 2 Genetic Variants Are Associated With Coronavirus Disease 2019.
J Infect Dis. 2021;224:2181-2183.
PubMed

WOODFORD J, Sagara I, Dicko A, Zeguime A, et al
Severe Acute Respiratory Syndrome Coronavirus 2 Seroassay Performance and Optimization in a Population With High Background Reactivity in Mali.
J Infect Dis. 2021;224:2001-2009.
PubMed Abstract available

KORSTEN K, Adriaenssens N, Coenen S, Butler CC, et al
World Health Organization Influenza-Like Illness Underestimates the Burden of Respiratory Syncytial Virus Infection in Community-Dwelling Older Adults.
J Infect Dis. 2021 Dec 14. pii: 6460601. doi: 10.1093.
PubMed Abstract available

BROCKMAN MA, Mwimanzi F, Lapointe HR, Sang Y, et al
Reduced magnitude and durability of humoral immune responses to COVID-19 mRNA vaccines among older adults.
J Infect Dis. 2021 Dec 9. pii: 6458430. doi: 10.1093.
PubMed Abstract available

NARANBHAI V, Garcia-Beltran WF, Chang CC, Mairena CB, et al
Comparative immunogenicity and effectiveness of mRNA-1273, BNT162b2 and Ad26.COV2.S COVID-19 vaccines.
J Infect Dis. 2021 Dec 9. pii: 6458467. doi: 10.1093.
PubMed Abstract available

SHOOK LL, Bordt EA, Meinsohn MC, Pepin D, et al
Placental Expression of ACE2 and TMPRSS2 in Maternal Severe Acute Respiratory Syndrome Coronavirus 2 Infection: Are Placental Defenses Mediated by Fetal Sex?
J Infect Dis. 2021;224.
PubMed Abstract available

ZHOU J, Choi S, Liu H, Zhang J, et al
Is SARS-CoV-2 Infection a Risk Factor for Early Pregnancy Loss? ACE2 and TMPRSS2 Coexpression and Persistent Replicative Infection in Primitive Trophoblast.
J Infect Dis. 2021;224.
PubMed Abstract available

ROBERTS DJ, Bebell LM, Edlow AG
Severe Acute Respiratory Syndrome Coronavirus 2 ACE2 and TMPRSS2 Receptor Protein Expression Patterns Throughout Gestation.
J Infect Dis. 2021;224.
PubMed Abstract available

HALFMANN P, Nakajima N, Sato Y, Takahashi K, et al
SARS-CoV-2 Interference of Influenza Virus Replication in Syrian Hamsters.
J Infect Dis. 2021 Dec 7. pii: 6454972. doi: 10.1093.
PubMed Abstract available

KIM G, Kim DH, Oh H, Bae S, et al
Germinal Center-Induced Immunity Is Correlated With Protection Against SARS-CoV-2 Reinfection But Not Lung Damage.
J Infect Dis. 2021;224:1861-1872.
PubMed Abstract available

BENDER JK, Meyer ED, Sandfort M, Matysiak-Klose D, et al
Low Sensitivity of Rapid Antigen Tests to Detect Severe Acute Respiratory Syndrome Coronavirus 2 Infections Before and on the Day of Symptom Onset in Nursing Home Staff and Residents, Germany, January-March 2021.
J Infect Dis. 2021;224:1987-1989.
PubMed

YONKER LM, Boucau J, Regan J, Choudhary MC, et al
Virologic Features of Severe Acute Respiratory Syndrome Coronavirus 2 Infection in Children.
J Infect Dis. 2021;224:1821-1829.
PubMed Abstract available

BOPPANA SB, Pinninti SG, Britt WJ
Coronavirus Disease 2019 and Children.
J Infect Dis. 2021;224:1807-1809.
PubMed

LAU CS, Aw TC
Frequent Severe Acute Respiratory Syndrome Coronavirus 2 Antigen Testing in a Disease-Free Population.
J Infect Dis. 2021;224:1986-1987.
PubMed

BIGGERSTAFF BJ, Akinbami LJ, Hales C, Chan PA, et al
Duration of Viral Nucleic Acid Shedding and Early Reinfection With Severe Respiratory Syndrome Coronavirus 2 in Healthcare Workers and First Responders.
J Infect Dis. 2021;224:1873-1877.
PubMed Abstract available

BOYAPATI A, Wipperman MF, Ehmann PJ, Hamon S, et al
Baseline Severe Acute Respiratory Syndrome Viral Load Is Associated With Coronavirus Disease 2019 Severity and Clinical Outcomes: Post Hoc Analyses of a Phase 2/3 Trial.
J Infect Dis. 2021;224:1830-1838.
PubMed Abstract available

PARK S, Michelow IC, Choe YJ
Shifting Patterns of Respiratory Virus Activity Following Social Distancing Measures for Coronavirus Disease 2019 in South Korea.
J Infect Dis. 2021;224:1900-1906.
PubMed Abstract available

November 2021

GILBOA M, Mandelboim M, Indenbaum V, Lustig Y, et al
Early Immunogenicity and safety of the third dose of BNT162b2 mRNA Covid-19 vaccine among adults older than 60 years; real world experience.
J Infect Dis. 2021 Nov 29. pii: 6446235. doi: 10.1093.
PubMed Abstract available

KIM JY, Lim SY, Park S, Kwon JS, et al
Immune responses to the ChAdOx1 nCoV-19 and BNT162b2 vaccines and to natural COVID-19 infections over a three-month period.
J Infect Dis. 2021 Nov 25. pii: 6440288. doi: 10.1093.
PubMed Abstract available

KUMAR S, Ghosh RS, Iyer H, Ray A, et al
Typhoid in India: An Age-old Problem With an Existing Solution.
J Infect Dis. 2021;224.
PubMed Abstract available

AMBROSINO D, Han HH, Hu B, Liang J, et al
Immunogenicity of SCB-2019 Coronavirus Disease 2019 Vaccine Compared With 4 Approved Vaccines.
J Infect Dis. 2021 Nov 19. pii: 6431853. doi: 10.1093.
PubMed Abstract available

FULDA ES, Fitch KV, Overton ET, Zanni MV, et al
COVID-19 Vaccination Rates in a Global HIV Cohort.
J Infect Dis. 2021 Nov 18. pii: 6431673. doi: 10.1093.
PubMed Abstract available

COLLIER AY, Yu J, Mcmahan K, Liu J, et al
COVID-19 mRNA Vaccine Immunogenicity in Immunosuppressed Individuals.
J Infect Dis. 2021 Nov 18. pii: 6430790. doi: 10.1093.
PubMed Abstract available

LEWIS AM, Zhang X, Brestoff JR
Coronavirus Disease 2019 Severity in Obese Patients May Be Linked to Viral Load and Immune Response.
J Infect Dis. 2021;224:1449-1451.
PubMed

EPSI NJ, Richard SA, Laing ED, Fries AC, et al
Clinical, Immunological, and Virological SARS-CoV-2 Phenotypes in Obese and Nonobese Military Health System Beneficiaries.
J Infect Dis. 2021;224:1462-1472.
PubMed Abstract available

PELLEAU S, Woudenberg T, Rosado J, Donnadieu F, et al
Kinetics of the Severe Acute Respiratory Syndrome Coronavirus 2 Antibody Response and Serological Estimation of Time Since Infection.
J Infect Dis. 2021;224:1489-1499.
PubMed Abstract available

ZHOU M, Yin Z, Xu J, Wang S, et al
Inflammatory Profiles and Clinical Features of Coronavirus 2019 Survivors 3 Months After Discharge in Wuhan, China.
J Infect Dis. 2021;224:1473-1488.
PubMed Abstract available

QUEEN J, Karaba S, Albin J, Karaba A, et al
The Time is Now: A Call for Renewed Support of Infectious Diseases Physician-Scientist Trainees in the Era of Coronavirus Disease 2019.
J Infect Dis. 2021;224:1452-1454.
PubMed

BIERLE DM, Ganesh R, Tulledge-Scheitel S, Hanson SN, et al
Monoclonal Antibody Treatment of Breakthrough COVID-19 in Fully Vaccinated Individuals with High-Risk Comorbidities.
J Infect Dis. 2021 Nov 16. pii: 6429422. doi: 10.1093.
PubMed Abstract available

JOHNSON S, Martinez CI, Tedjakusuma SN, Peinovich N, et al
Oral vaccination protects against SARS-CoV-2 in a Syrian hamster challenge model.
J Infect Dis. 2021 Nov 10. pii: 6425228. doi: 10.1093.
PubMed Abstract available

FERREIRA VH, Marinelli T, Ierullo M, Ku T, et al
SARS-CoV-2 infection induces greater T-cell responses compared to vaccination in solid organ transplant recipients.
J Infect Dis. 2021 Nov 5. pii: 6406613. doi: 10.1093.
PubMed Abstract available

SACIUK Y, Kertes J, Shamir Stein N, Ekka Zohar A, et al
Effectiveness of a third dose of BNT162b2 mRNA vaccine.
J Infect Dis. 2021 Nov 2. pii: 6415586. doi: 10.1093.
PubMed Abstract available

October 2021

HUKIC M, Avdihodzic H, Veledar E, Korkut E, et al
Potential Effect of Previous Human Coronavirus NL63 Infection on the Rate of Infection and the Clinical Course of Coronavirus Disease 2019.
J Infect Dis. 2021;224:1444-1445.
PubMed

STOSOR V, Angarone MP
Not All Monoclonal Antibodies for Coronavirus Disease 2019 Are Created Equal.
J Infect Dis. 2021;224:1275-1277.
PubMed

HORTON DB, Barrett ES, Roy J, Gennaro ML, et al
Determinants and Dynamics of SARS-CoV-2 Infection in a Diverse Population: 6-Month Evaluation of a Prospective Cohort Study.
J Infect Dis. 2021;224:1345-1356.
PubMed Abstract available

YANG Y, Kuang L, Li L, Wu Y, et al
Distinct Mitochondria-Mediated T-Cell Apoptosis Responses in Children and Adults With Coronavirus Disease 2019.
J Infect Dis. 2021;224:1333-1344.
PubMed Abstract available

SANTOS BRAVO M, Nicolas D, Berengua C, Fernandez M, et al
Severe Acute Respiratory Syndrome Coronavirus 2 Normalized Viral Loads and Subgenomic RNA Detection as Tools for Improving Clinical Decision Making and Work Reincorporation.
J Infect Dis. 2021;224:1325-1332.
PubMed Abstract available

BJORKMAN KK, Saldi TK, Lasda E, Bauer LC, et al
Higher Viral Load Drives Infrequent Severe Acute Respiratory Syndrome Coronavirus 2 Transmission Between Asymptomatic Residence Hall Roommates.
J Infect Dis. 2021;224:1316-1324.
PubMed Abstract available

LI K, Wohlford-Lenane C, Bartlett JA, McCray PB, et al
Intersubject Variation in ACE2 Protein Expression in Human Airway Epithelia and Its Relationship to Severe Acute Respiratory Syndrome Coronavirus 2.
J Infect Dis. 2021;224:1357-1361.
PubMed Abstract available

GANESH R, Philpot LM, Bierle DM, Anderson RJ, et al
Real-World Clinical Outcomes of Bamlanivimab and Casirivimab-Imdevimab Among High-Risk Patients With Mild to Moderate Coronavirus Disease 2019.
J Infect Dis. 2021;224:1278-1286.
PubMed Abstract available

SHRWANI K, Sharma R, Krishnan M, Jones T, et al
Detection of Serum Cross-Reactive Antibodies and Memory Response to SARS-CoV-2 in Prepandemic and Post-COVID-19 Convalescent Samples.
J Infect Dis. 2021;224:1305-1315.
PubMed Abstract available

DE GIORGI V, West KA, Henning AN, Chen LN, et al
Naturally Acquired SARS-CoV-2 Immunity Persists for Up to 11 Months Following Infection.
J Infect Dis. 2021;224:1294-1304.
PubMed Abstract available

DIMCHEFF DE, Valesano AL, Rumfelt KE, Fitzsimmons WJ, et al
Severe Acute Respiratory Syndrome Coronavirus 2 Total and Subgenomic RNA Viral Load in Hospitalized Patients.
J Infect Dis. 2021;224:1287-1293.
PubMed Abstract available

OWUSU D, Pomeroy MA, Lewis NM, Wadhwa A, et al
Persistent SARS-CoV-2 RNA Shedding Without Evidence of Infectiousness: A Cohort Study of Individuals With COVID-19.
J Infect Dis. 2021;224:1362-1371.
PubMed Abstract available

MEIJIDE MIGUEZ H, Ochando Gomez M, Montes Garcia I, Garcia Merino IM, et al
Cellular and humoral response, six months after two doses of BNT162b2 mRNA Covid 19 vaccination, in residents and staff of nursing homes for the elderly.
J Infect Dis. 2021 Oct 28. pii: 6413766. doi: 10.1093.
PubMed

WITHANAGE K, De Coster I, Cools N, Viviani S, et al
Phase 1 randomized, placebo-controlled, dose-escalating study to evaluate OVX836, a nucleoprotein-based influenza vaccine: intramuscular results.
J Infect Dis. 2021 Oct 15. pii: 6398205. doi: 10.1093.
PubMed Abstract available

WIDERA M, Wilhelm A, Hoehl S, Pallas C, et al
Limited Neutralization of Authentic Severe Acute Respiratory Syndrome Coronavirus 2 Variants Carrying E484K In Vitro.
J Infect Dis. 2021;224:1109-1114.
PubMed Abstract available

DO LAH, Tsedenbal N, von Mollendorf C, Mungun T, et al
Exploring the Possible Cause of the Dramatic Increase in Measles Mortality During the 2015-2016 Mongolian Outbreak.
J Infect Dis. 2021;224:1266-1268.
PubMed

LEMARIE B, Boussaid G, Gault E, Prigent H, et al
Predictors of hospitalization and superinfection in viral respiratory tract infections between influenza and paramyxoviruses: the SUPERFLUOUS study.
J Infect Dis. 2021 Oct 12. pii: 6390777. doi: 10.1093.
PubMed Abstract available

PETERSON JT, Zareba AM, Fitz-Patrick D, Essink BJ, et al
Safety and Immunogenicity of a Respiratory Syncytial Virus Prefusion F Vaccine When Co-Administered With a Tetanus, Diphtheria, and Acellular Pertussis Vaccine.
J Infect Dis. 2021 Oct 12. pii: 6391485. doi: 10.1093.
PubMed Abstract available

DODD RY, Notari EP, Brodsky JP, Foster GA, et al
Patterns of antibody response to SARS-CoV-2 among 1.6 million blood donors: Impact of vaccination, United States December 2020 - June 2021.
J Infect Dis. 2021 Oct 9. pii: 6385747. doi: 10.1093.
PubMed Abstract available

LU Y, Jiao Y, Graham DJ, Wu Y, et al
Risk factors for COVID-19 deaths among elderly nursing home Medicare beneficiaries in the pre-vaccine period.
J Infect Dis. 2021 Oct 7. pii: 6383455. doi: 10.1093.
PubMed Abstract available

September 2021

BECKER T, Elbahesh H, Reperant LA, Rimmelzwaan GF, et al
Influenza Vaccines: Successes and Continuing Challenges.
J Infect Dis. 2021;224.
PubMed Abstract available

PELUSO MJ, Lu S, Tang AF, Durstenfeld MS, et al
Markers of Immune Activation and Inflammation in Individuals With Postacute Sequelae of Severe Acute Respiratory Syndrome Coronavirus 2 Infection.
J Infect Dis. 2021 Sep 27. pii: 6376537. doi: 10.1093.
PubMed Abstract available

QI Y, Shaman J, Pei S
Quantifying the impact of COVID-19 non-pharmaceutical interventions on influenza transmission in the United States.
J Infect Dis. 2021 Sep 22. pii: 6374002. doi: 10.1093.
PubMed Abstract available

XIAO J, de Mesquita JB, Leung NHL, Adenaiye O, et al
Viral RNA and infectious influenza virus on mobile phones of influenza patients in Hong Kong and the United States.
J Infect Dis. 2021 Sep 17. pii: 6371826. doi: 10.1093.
PubMed Abstract available

GORSE GJ, Rattigan SM, Kirpich A, Simberkoff MS, et al
Influence of Pre-Season Antibodies against Influenza Virus on Risk of Influenza Infection among Health Care Personnel.
J Infect Dis. 2021 Sep 17. pii: 6371937. doi: 10.1093.
PubMed Abstract available

BEVERLAND A, Keogan M, Connell J, De Gascun C, et al
Longitudinal Serological Analysis Following a National Seroprevalence Study to Investigate COVID-19 Infection in People Living in Ireland.
J Infect Dis. 2021;224:1100-1101.
PubMed

TONG M, Zheng Q, Chen F, Zhu Y, et al
Comment on: Cell Adhesion Molecules and Vascular Endothelial Growth Factor at the Systemic and Alveolar Level in Coronavirus Disease 2019 Acute Respiratory Distress Syndrome.
J Infect Dis. 2021;224:1103-1104.
PubMed

KRISTENSEN MK, Plovsing RR, Berg RMG, Krogh-Madsen R, et al
Cell Adhesion Molecules and Vascular Endothelial Growth Factor at the Systemic and Alveolar Level in Coronavirus Disease 2019 Acute Respiratory Distress Syndrome.
J Infect Dis. 2021;224:1101-1103.
PubMed

CHOE PG, Kang CK, Kim KH, Yi J, et al
Persistence of Neutralizing Antibody Response up to 1 Year After Asymptomatic or Symptomatic SARS-CoV-2 Infection.
J Infect Dis. 2021;224:1097-1099.
PubMed

ERREN TC, Lewis P, Morfeld P
Factoring in Coronavirus Disease 2019 Seasonality: Experiences From Germany.
J Infect Dis. 2021;224:1096.
PubMed

HEATON PM
Herd Immunity: The Journey Is as Important as the Destination.
J Infect Dis. 2021;224:931-933.
PubMed

FERREIRA IATM, Kemp SA, Datir R, Saito A, et al
SARS-CoV-2 B.1.617 Mutations L452R and E484Q Are Not Synergistic for Antibody Evasion.
J Infect Dis. 2021;224:989-994.
PubMed Abstract available

SMITH RL, Gibson LL, Martinez PP, Ke R, et al
Longitudinal Assessment of Diagnostic Test Performance Over the Course of Acute SARS-CoV-2 Infection.
J Infect Dis. 2021;224:976-982.
PubMed Abstract available

KOECKERLING D, Barker J
Accelerating the Evolution of Severe Acute Respiratory Syndrome Coronavirus 2: A Risk of Combining Dexamethasone and Tocilizumab for Severe Coronavirus Disease 2019.
J Infect Dis. 2021;224:934-937.
PubMed Abstract available

CHO K, Keithly SC, Kurgansky KE, Madenci AL, et al
Early Convalescent Plasma Therapy and Mortality Among US Veterans Hospitalized With Nonsevere COVID-19: An Observational Analysis Emulating a Target Trial.
J Infect Dis. 2021;224:967-975.
PubMed Abstract available

RYU S, Hwang Y, Ali ST, Kim DS, et al
Decreased Use of Broad-Spectrum Antibiotics During the Coronavirus Disease 2019 Epidemic in South Korea.
J Infect Dis. 2021;224:949-955.
PubMed Abstract available

GRZELAK L, Velay A, Madec Y, Gallais F, et al
Sex Differences in the Evolution of Neutralizing Antibodies to Severe Acute Respiratory Syndrome Coronavirus 2.
J Infect Dis. 2021;224:983-988.
PubMed Abstract available

SUNTARATTIWONG P, Mott JA, Mohanty S, Sinthuwattanawibool C, et al
Feasibility and Performance of Self-Collected Nasal Swabs for Detection of Influenza Virus, Respiratory Syncytial Virus, and Human Metapneumovirus.
J Infect Dis. 2021;224:831-838.
PubMed Abstract available

HILL KJ, Dewar R, Templeton K
A Multiregional Evaluation of Cycle Threshold Values in Severe Acute Respiratory Syndrome Coronavirus 2 VOC-20DEC-01 Variant.
J Infect Dis. 2021;224:927-928.
PubMed

RAN S, Su K, Zhang S, Liu B, et al
The Association Between Coronavirus Disease 2019 Infection and Blood Constituents: A Mendelian Randomization Analysis.
J Infect Dis. 2021;224:922-924.
PubMed

KIM MH, Salloum S, Wang JY, Wong LP, et al
Type I, II, and III Interferon Signatures Correspond to Coronavirus Disease 2019 Severity.
J Infect Dis. 2021;224:777-782.
PubMed Abstract available

NOH JY, Kwak JE, Yang JS, Hwang SY, et al
Longitudinal Assessment of Antisevere Acute Respiratory Syndrome Coronavirus 2 Immune Responses for Six Months Based on the Clinical Severity of Coronavirus Disease 2019.
J Infect Dis. 2021;224:754-763.
PubMed Abstract available

PATI A, Padhi S, Panda D, Suvankar S, et al
A CD14 Polymorphism (C-159T rs2569190) Is Associated With SARS-CoV-2 Infection and Mortality in the European Population.
J Infect Dis. 2021;224:921-922.
PubMed

ABDELNABI R, Foo CS, De Jonghe S, Maes P, et al
Molnupiravir Inhibits Replication of the Emerging SARS-CoV-2 Variants of Concern in a Hamster Infection Model.
J Infect Dis. 2021;224:749-753.
PubMed Abstract available

PEREZ-LAGO L, Martinez-Lozano H, Pajares Diaz JA, Diaz Gomez A, et al
Proper Assignation of Reactivation in a COVID-19 Recurrence Initially Interpreted as a Reinfection.
J Infect Dis. 2021;224:788-792.
PubMed Abstract available

PICHLER D, Baumgartner M, Kimpel J, Rossler A, et al
Marked Increase in Avidity of SARS-CoV-2 Antibodies 7-8 Months After Infection Is Not Diminished in Old Age.
J Infect Dis. 2021;224:764-770.
PubMed Abstract available

TSANG TK, Wu P, Lau EHY, Cowling BJ, et al
Accounting for Imported Cases in Estimating the Time-Varying Reproductive Number of Coronavirus Disease 2019 in Hong Kong.
J Infect Dis. 2021;224:783-787.
PubMed Abstract available

RAZANI N, Malekinejad M, Rutherford GW
Clarification Regarding "Outdoor Transmission of SARS-CoV-2 and Other Respiratory Viruses: A Systematic Review".
J Infect Dis. 2021;224:925-926.
PubMed

KILLERBY ME, Ata Ur Rasheed M, Tamin A, Harcourt JL, et al
Shedding of Culturable Virus, Seroconversion, and 6-Month Follow-up Antibody Responses in the First 14 Confirmed Cases of Coronavirus Disease 2019 in the United States.
J Infect Dis. 2021;224:771-776.
PubMed Abstract available

LANE STARR NM, Evans MD, Lee KE, Gern JE, et al
Ensemble Analysis Identifies Nasal 15-Keto-PGE2 as a Predictor of Recovery in Experimental Rhinovirus Colds.
J Infect Dis. 2021;224:839-849.
PubMed Abstract available

August 2021

GIURGEA LT, Cervantes-Medina A, Walters KA, Scherler K, et al
Sex Differences in Influenza: The Challenge Study Experience.
J Infect Dis. 2021 Aug 23. pii: 6356350. doi: 10.1093.
PubMed Abstract available

LINNIK J, Syedbasha M, Kaltenbach HM, Vogt D, et al
Association of host factors with antibody response to seasonal influenza vaccination in allogeneic hematopoietic stem cell transplant (HSCT) patients.
J Infect Dis. 2021 Aug 20. pii: 6355382. doi: 10.1093.
PubMed Abstract available

DE MIGUEL BUCKLEY R, Diaz-Menendez M, Garcia-Rodriguez J, Arribas JR, et al
Seasonal coronavirus pneumonia after SARS-Cov-2 infection and vaccine: new frenemies?
J Infect Dis. 2021 Aug 20. pii: 6355378. doi: 10.1093.
PubMed

NATHAN N, Prevost B, Lambert S, Schnuriger A, et al
SARS-CoV-2 variant Delta infects all 6 siblings but spares Comirnaty (BNT162b2, BioNTech/Pfizer)-vaccinated parents.
J Infect Dis. 2021 Aug 19. pii: 6354728. doi: 10.1093.
PubMed

YANG CY, Lee YY, Wei JC
Interpreting prevention of COVID-19 and vaccines.
J Infect Dis. 2021 Aug 18. pii: 6354219. doi: 10.1093.
PubMed

PEART AKINDELE N, Kouo T, Karaba AH, Gordon O, et al
Distinct Cytokine and Chemokine Dysregulation in Hospitalized Children With Acute Coronavirus Disease 2019 and Multisystem Inflammatory Syndrome With Similar Levels of Nasopharyngeal Severe Acute Respiratory Syndrome Coronavirus 2 Shedding.
J Infect Dis. 2021;224:606-615.
PubMed Abstract available

BARLEV-GROSS M, Weiss S, Paran N, Yahalom-Ronen Y, et al
Sensitive Immunodetection of Severe Acute Respiratory Syndrome Coronavirus 2 Variants of Concern 501Y.V2 and 501Y.V1.
J Infect Dis. 2021;224:616-619.
PubMed Abstract available

MAZZITELLI I, Bleichmar L, Luduena MG, Pisarevsky A, et al
Immunoglobulin G Immune Complexes May Contribute to Neutrophil Activation in the Course of Severe Coronavirus Disease 2019.
J Infect Dis. 2021;224:575-585.
PubMed Abstract available

BANDOPADHYAY P, D'Rozario R, Lahiri A, Sarif J, et al
Nature and Dimensions of Systemic Hyperinflammation and its Attenuation by Convalescent Plasma in Severe COVID-19.
J Infect Dis. 2021;224:565-574.
PubMed Abstract available

PADHI S, Sahu S, Pati A, Mohanty AK, et al
Minor Allele of Intercellular Adhesion Molecule-1 Polymorphism (rs5498 1462A>G) Is Associated With SARS-CoV-2 Infection and Related Mortality.
J Infect Dis. 2021;224:734-735.
PubMed

RATCLIFF J, Nguyen D, Fish M, Rynne J, et al
Virological Characterization of Critically Ill Patients With COVID-19 in the United Kingdom: Interactions of Viral Load, Antibody Status, and B.1.1.7 Infection.
J Infect Dis. 2021;224:595-605.
PubMed Abstract available

YAO L, Wang GL, Shen Y, Wang ZY, et al
Persistence of Antibody and Cellular Immune Responses in Coronavirus Disease 2019 Patients Over Nine Months After Infection.
J Infect Dis. 2021;224:586-594.
PubMed Abstract available

SOUTHWICK FS
Improving the Definition of Coronavirus Disease 2019-Related Deaths.
J Infect Dis. 2021;224:375-376.
PubMed

AVIV R, Weber A, Anzum T, Federbush M, et al
Prolonged Coronavirus Disease 2019 in a Patient With Rheumatoid Arthritis on Rituximab Therapy.
J Infect Dis. 2021;224:557-559.
PubMed

ALLAN-BLITZ LT, Klausner JD
Reply: Seroprevalence of SARS-CoV-2 After the Largest Initial Epidemic Wave in the United States: Findings from New York City, May 13-July 21, 2020.
J Infect Dis. 2021;224:556-557.
PubMed

HALL JA, Harris RJ, Emmett HE, Lowe B, et al
On the Sensitivity and Specificity of Postmortem Upper Respiratory Tract Testing for SARS-CoV-2.
J Infect Dis. 2021;224:389-394.
PubMed Abstract available

MEISTER TL, Fortmann J, Todt D, Heinen N, et al
Comparable Environmental Stability and Disinfection Profiles of the Currently Circulating SARS-CoV-2 Variants of Concern B.1.1.7 and B.1.351.
J Infect Dis. 2021;224:420-424.
PubMed Abstract available

ALKHARAAN H, Bayati S, Hellstrom C, Aleman S, et al
Persisting Salivary IgG Against SARS-CoV-2 at 9 Months After Mild COVID-19: A Complementary Approach to Population Surveys.
J Infect Dis. 2021;224:407-414.
PubMed Abstract available

BOUMAZA A, Gay L, Mezouar S, Bestion E, et al
Monocytes and Macrophages, Targets of Severe Acute Respiratory Syndrome Coronavirus 2: The Clue for Coronavirus Disease 2019 Immunoparalysis.
J Infect Dis. 2021;224:395-406.
PubMed Abstract available

July 2021

EIDEN J, Volckaert B, Rudenko O, Aitchison R, et al
Single Replication M2SR Influenza Vaccine Induced Immune Responses Associated with Protection Against Human Challenge with Highly Drifted H3N2 Influenza Strain.
J Infect Dis. 2021 Jul 29. pii: 6330582. doi: 10.1093.
PubMed Abstract available

GIL RM, Freeman T, Mathew T, Kullar R, et al
The LGBTQ+ communities and the COVID-19 pandemic: a call to break the cycle of structural barriers.
J Infect Dis. 2021 Jul 29. pii: 6330600. doi: 10.1093.
PubMed Abstract available

PARROTT JC, Maleki AN, Vassor VE, Osahan S, et al
Prevalence of SARS-CoV-2 Antibodies in New York City Adults, June-October 2020: A Population-Based Survey.
J Infect Dis. 2021;224:188-195.
PubMed Abstract available

CASADO JL, Vizcarra P, Velasco H, Hammerle J, et al
Progressive and Parallel Decline of Humoral and T-Cell Immunity in Convalescent Healthcare Workers with Asymptomatic or Mild-to-Moderate Severe Acute Respiratory Syndrome Coronavirus 2 Infection.
J Infect Dis. 2021;224:241-245.
PubMed Abstract available

PANDA AK, Pati A, Padhi S, Sahoo AK, et al
Association of Granulin rs5848 (C>T) Polymorphism With Severe Acute Respiratory Syndrome Coronavirus 2 Infection and Mortality Rate.
J Infect Dis. 2021;224:366-367.
PubMed

BERNAL E, Gimeno L, Alcaraz MJ, Quadeer AA, et al
Activating Killer-Cell Immunoglobulin-Like Receptors Are Associated With the Severity of Coronavirus Disease 2019.
J Infect Dis. 2021;224:229-240.
PubMed Abstract available

JALKANEN P, Pasternack A, Maljanen S, Melen K, et al
A Combination of N and S Antigens With IgA and IgG Measurement Strengthens the Accuracy of SARS-CoV-2 Serodiagnostics.
J Infect Dis. 2021;224:218-228.
PubMed Abstract available

VILLARINO E, Deng X, Kemper CA, Jorden MA, et al
Introduction, Transmission Dynamics, and Fate of Early Severe Acute Respiratory Syndrome Coronavirus 2 Lineages in Santa Clara County, California.
J Infect Dis. 2021;224:207-217.
PubMed Abstract available

PATHELA P, Crawley A, Weiss D, Maldin B, et al
Seroprevalence of Severe Acute Respiratory Syndrome Coronavirus 2 Following the Largest Initial Epidemic Wave in the United States: Findings From New York City, 13 May to 21 July 2020.
J Infect Dis. 2021;224:196-206.
PubMed Abstract available

HALL MD, Anderson JM, Anderson A, Baker D, et al
Report of the National Institutes of Health SARS-CoV-2 Antiviral Therapeutics Summit.
J Infect Dis. 2021;224.
PubMed Abstract available

YEO KT, Yung CF, Khoo PC, Saffari SE, et al
Effectiveness of Palivizumab Against Respiratory Syncytial Virus Hospitalization Among Preterm Infants in a Setting With Year-Round Circulation.
J Infect Dis. 2021;224:279-287.
PubMed Abstract available

BERBERS G, Mollema L, van der Klis F, den Hartog G, et al
Antibody Responses to Respiratory Syncytial Virus: A Cross-Sectional Serosurveillance Study in the Dutch Population Focusing on Infants Younger Than 2 Years.
J Infect Dis. 2021;224:269-278.
PubMed Abstract available

SYED F, Li W, Relich RF, Russell PM, et al
Excessive Matrix Metalloproteinase-1 and Hyperactivation of Endothelial Cells Occurred in COVID-19 Patients and Were Associated With the Severity of COVID-19.
J Infect Dis. 2021;224:60-69.
PubMed Abstract available

DA SILVA ANTUNES R, Pallikkuth S, Williams E, Dawen Yu E, et al
Differential T-Cell Reactivity to Endemic Coronaviruses and SARS-CoV-2 in Community and Health Care Workers.
J Infect Dis. 2021;224:70-80.
PubMed Abstract available

PETRIE JG, Bazzi LA, McDermott AB, Follmann D, et al
Coronavirus Occurrence in the Household Influenza Vaccine Evaluation (HIVE) Cohort of Michigan Households: Reinfection Frequency and Serologic Responses to Seasonal and Severe Acute Respiratory Syndrome Coronaviruses.
J Infect Dis. 2021;224:49-59.
PubMed Abstract available

KANG CK, Kim M, Lee S, Kim G, et al
Longitudinal Analysis of Human Memory T-Cell Response According to the Severity of Illness up to 8 Months After Severe Acute Respiratory Syndrome Coronavirus 2 Infection.
J Infect Dis. 2021;224:39-48.
PubMed Abstract available

DEE K, Goldfarb DM, Haney J, Amat JAR, et al
Human Rhinovirus Infection Blocks Severe Acute Respiratory Syndrome Coronavirus 2 Replication Within the Respiratory Epithelium: Implications for COVID-19 Epidemiology.
J Infect Dis. 2021;224:31-38.
PubMed Abstract available

KRAAY ANM, Han P, Kambhampati AK, Wikswo ME, et al
Impact of Nonpharmaceutical Interventions for Severe Acute Respiratory Syndrome Coronavirus 2 on Norovirus Outbreaks: An Analysis of Outbreaks Reported By 9 US States.
J Infect Dis. 2021;224:9-13.
PubMed Abstract available

DILLNER J, Elfstrom KM, Blomqvist J, Engstrand L, et al
High Amounts of SARS-CoV-2 Precede Sickness Among Asymptomatic Health Care Workers.
J Infect Dis. 2021;224:14-20.
PubMed Abstract available

GIACOMELLI CAO R, Christian L, Xu Z, Jaramillo L, et al
Early changes in interferon gene expression and antibody responses following influenza vaccination in pregnant women.
J Infect Dis. 2021 Jul 1. pii: 6312681. doi: 10.1093.
PubMed Abstract available

June 2021

SCHWARZ TF, Johnson C, Grigat C, Apter D, et al
Three dose levels of a maternal respiratory syncytial virus vaccine candidate are well tolerated and immunogenic in a randomized trial in non-pregnant women.
J Infect Dis. 2021 Jun 19. pii: 6306104. doi: 10.1093.
PubMed Abstract available

MA Y, Liu F, Lin T, Chen L, et al
Large-scale identification of T cell epitopes derived from SARS-CoV-2 for the development of peptide vaccines against COVID-19.
J Infect Dis. 2021 Jun 18. pii: 6305142. doi: 10.1093.
PubMed Abstract available

BRAUNSTEIN SL, Slutsker JS, Lazar R, Shah D, et al
Epidemiology of reported HIV and other sexually transmitted infections during the COVID-19 pandemic, New York City.
J Infect Dis. 2021 Jun 16. pii: 6301136. doi: 10.1093.
PubMed Abstract available

HAAGMANS BL, Noack D, Okba NMA, Li W, et al
SARS-CoV-2 Neutralizing Human Antibodies Protect Against Lower Respiratory Tract Disease in a Hamster Model.
J Infect Dis. 2021;223:2020-2028.
PubMed Abstract available

HAWLEY HB, Chang JC
Complement-Induced Endotheliopathy-Associated Vascular Microthrombosis in Coronavirus Disease 2019.
J Infect Dis. 2021;223:2198-2199.
PubMed

DEMONBREUN AR, Sancilio A, Velez ME, Ryan DT, et al
COVID-19 mRNA vaccination generates greater IgG levels in women compared to men.
J Infect Dis. 2021 Jun 12. pii: 6297423. doi: 10.1093.
PubMed Abstract available

RAMOS DA SILVA S, Ju E, Meng W, Paniz Mondolfi AE, et al
Broad Severe Acute Respiratory Syndrome Coronavirus 2 Cell Tropism and Immunopathology in Lung Tissues From Fatal Coronavirus Disease 2019.
J Infect Dis. 2021;223:1842-1854.
PubMed Abstract available

ROSENBERG ES, Tesoriero JM
A Tale of Many New York Cities.
J Infect Dis. 2021 Jun 4. pii: 6291934. doi: 10.1093.
PubMed

RINGLANDER J, Nilsson S, Westin J, Lindh M, et al
Low Incidence of Reinfection With Endemic Coronaviruses Diagnosed by Real-Time PCR.
J Infect Dis. 2021;223:2013-2014.
PubMed

May 2021

SCHNIERLE BS
Reply to Ringlander et al.
J Infect Dis. 2021;223:1833.
PubMed

RINGLANDER J, Martner A, Nilsson S, Westin J, et al
Incidence and Severity of Covid-19 in Patients with and without Previously Verified Infections with Common Cold Coronaviruses.
J Infect Dis. 2021;223:1831-1832.
PubMed

LU L, Koh CT, Lim YH, Sng A, et al
Role of Asymptomatic Children in Community Severe Acute Respiratory Syndrome Coronavirus 2 Transmission.
J Infect Dis. 2021;223:1834-1836.
PubMed

HAYMOND A, Damluji AA, Narayanan A, Mueller C, et al
Durability of Viral Neutralization in Asymptomatic Coronavirus Disease 2019 for at Least 60 Days.
J Infect Dis. 2021;223:1677-1680.
PubMed Abstract available

ACOSTA-AMPUDIA Y, Rojas M, Monsalve DM, Rodriguez Y, et al
Comment on: Nature and Dimensions of the Systemic Hyper-inflammation and Its Attenuation by Convalescent Plasma in Severe COVID-19.
J Infect Dis. 2021;223:1833-1834.
PubMed

PEREIRA C, Harris BHL, Di Giovannantonio M, Rosadas C, et al
The Association Between Antibody Response to Severe Acute Respiratory Syndrome Coronavirus 2 Infection and Post-COVID-19 Syndrome in Healthcare Workers.
J Infect Dis. 2021;223:1671-1676.
PubMed Abstract available

LEMIEUX JE, Li JZ
Uncovering Ways That Emerging Severe Acute Respiratory Syndrome Coronavirus 2 Lineages May Increase Transmissibility.
J Infect Dis. 2021;223:1663-1665.
PubMed

KIDD M, Richter A, Best A, Cumley N, et al
S-Variant SARS-CoV-2 Lineage B1.1.7 Is Associated With Significantly Higher Viral Load in Samples Tested by TaqPath Polymerase Chain Reaction.
J Infect Dis. 2021;223:1666-1670.
PubMed Abstract available

DAWOOD FS, Varner M, Munoz F, Stockwell MS, et al
Respiratory Viral Infections and Infection Prevention Practices among Women with Acute Respiratory Illness during Delivery Hospitalizations during the 2019-2020 Influenza Season.
J Infect Dis. 2021 May 25. pii: 6284115. doi: 10.1093.
PubMed Abstract available

XIE C, Su W, Sia SF, Choy KT, et al
A(H1N1)pdm09 influenza viruses replicating in ferret upper or lower respiratory tract differed in onward transmission potential by air.
J Infect Dis. 2021 May 24. pii: 6283765. doi: 10.1093.
PubMed Abstract available

FELDSTEIN LR, Ferdinands JM, Self WH, Randolph AG, et al
Modeling the impacts of clinical influenza testing on influenza vaccine effectiveness estimates.
J Infect Dis. 2021 May 20. pii: 6278475. doi: 10.1093.
PubMed Abstract available

SYNOLAKI E, Papadopoulos V, Divolis G, Tsahouridou O, et al
The Activin/Follistatin Axis Is Severely Deregulated in COVID-19 and Independently Associated With In-Hospital Mortality.
J Infect Dis. 2021;223:1544-1554.
PubMed Abstract available

AVADHANULA V, Nicholson EG, Ferlic-Stark L, Piedra FA, et al
Viral Load of Severe Acute Respiratory Syndrome Coronavirus 2 in Adults During the First and Second Wave of Coronavirus Disease 2019 Pandemic in Houston, Texas: The Potential of the Superspreader.
J Infect Dis. 2021;223:1528-1537.
PubMed Abstract available

RAMAN RS, Bhagwan Barge V, Anil Kumar D, Dandu H, et al
A Phase II Safety and Efficacy Study on Prognosis of Moderate Pneumonia in Coronavirus Disease 2019 Patients With Regular Intravenous Immunoglobulin Therapy.
J Infect Dis. 2021;223:1538-1543.
PubMed Abstract available

TARHINI H, Recoing A, Bridier-Nahmias A, Rahi M, et al
Long-Term Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infectiousness Among Three Immunocompromised Patients: From Prolonged Viral Shedding to SARS-CoV-2 Superinfection.
J Infect Dis. 2021;223:1522-1527.
PubMed Abstract available

RICHARDS KA, Glover M, Crawford JC, Thomas PG, et al
Circulating CD4 T Cells Elicited by Endemic Coronaviruses Display Vast Disparities in Abundance and Functional Potential Linked to Antigen Specificity and Age.
J Infect Dis. 2021;223:1555-1563.
PubMed Abstract available

CHEN J, Vitetta L
Increased PD-L1 Expression May Be Associated With the Cytokine Storm and CD8+ T-Cell Exhaustion in Severe COVID-19.
J Infect Dis. 2021;223:1659-1660.
PubMed

OUWENDIJK WJD, Raadsen MP, van Kampen JJA, Verdijk RM, et al
High Levels of Neutrophil Extracellular Traps Persist in the Lower Respiratory Tract of Critically Ill Patients With Coronavirus Disease 2019.
J Infect Dis. 2021;223:1512-1521.
PubMed Abstract available

TELUGUAKULA N
Neutrophils Set Extracellular Traps to Injure Lungs in Coronavirus Disease 2019.
J Infect Dis. 2021;223:1503-1505.
PubMed

CHU CY, Qiu X, McCall MN, Wang L, et al
Airway Gene Expression Correlates of Respiratory Syncytial Virus Disease Severity and Microbiome Composition in Infants.
J Infect Dis. 2021;223:1639-1649.
PubMed Abstract available

GRIER A, Gill AL, Kessler HA, Corbett A, et al
Temporal Dysbiosis of Infant Nasal Microbiota Relative to Respiratory Syncytial Virus Infection.
J Infect Dis. 2021;223:1650-1658.
PubMed Abstract available

BIANCHI FP, Germinario CA, Migliore G, Vimercati L, et al
BNT162b2 mRNA Covid-19 vaccine effectiveness in the prevention of SARS-CoV-2 infection: a preliminary report.
J Infect Dis. 2021 May 19. pii: 6278131. doi: 10.1093.
PubMed Abstract available

JOFFE S, Babiker A, Ellenberg SS, Fix A, et al
Data and Safety Monitoring of COVID-19 Vaccine Clinical Trials.
J Infect Dis. 2021 May 19. pii: 6278127. doi: 10.1093.
PubMed Abstract available

COREY L
Behind the Scenes Heroes: the COVID-19 Vaccine Data and Safety Monitoring Board.
J Infect Dis. 2021 May 19. pii: 6278073. doi: 10.1093.
PubMed

CHA S, Henry A, Montgomery MP, Laws RL, et al
Morbidity and Mortality among Adults Experiencing Homelessness Hospitalized with COVID-19.
J Infect Dis. 2021 May 16. pii: 6276529. doi: 10.1093.
PubMed Abstract available

BARTSCH SM, Wedlock PT, O'Shea KJ, Cox SN, et al
Lives and Costs Saved by Expanding and Expediting COVID-19 Vaccination.
J Infect Dis. 2021 May 6. pii: 6267841. doi: 10.1093.
PubMed Abstract available

April 2021

BAO L, Song Z, Xue J, Gao H, et al
Susceptibility and Attenuated Transmissibility of SARS-CoV-2 in Domestic Cats.
J Infect Dis. 2021;223:1313-1321.
PubMed Abstract available

DAVIS MF, Innes GK
The Cat's in the Bag: Despite Limited Cat-to-Cat Severe Acute Respiratory Syndrome Coronavirus 2 Transmission, One Health Surveillance Efforts Are Needed.
J Infect Dis. 2021;223:1309-1312.
PubMed

LUZZATTO-FEGIZ P, Temprano-Coleto F, Peaudecerf FJ, Landel JR, et al
UVB Radiation Alone May Not Explain Sunlight Inactivation of SARS-CoV-2.
J Infect Dis. 2021;223:1500-1502.
PubMed

JANSSEN NAF, Grondman I, de Nooijer AH, Boahen CK, et al
Dysregulated Innate and Adaptive Immune Responses Discriminate Disease Severity in COVID-19.
J Infect Dis. 2021;223:1322-1333.
PubMed Abstract available

BAUER W, Ulke J, Galtung N, Strasser-Marsik LC, et al
Role of Cell Adhesion Molecules for Prognosis of Disease Development of Patients With and Without COVID-19 in the Emergency Department.
J Infect Dis. 2021;223:1497-1499.
PubMed

THIEDE JM, Gress AR, Libby SD, Ronayne CE, et al
Immune Profiling to Determine Early Disease Trajectories Associated With Coronavirus Disease 2019 Mortality Rate: A Substudy from the ACTT-1 Trial.
J Infect Dis. 2021;223:1339-1344.
PubMed Abstract available

BOLOTIN S, Tran V, Osman S, Brown KA, et al
SARS-CoV-2 Seroprevalence Survey Estimates Are Affected by Anti-Nucleocapsid Antibody Decline.
J Infect Dis. 2021;223:1334-1338.
PubMed Abstract available

KALKOWSKA DA, Pallansch MA, Cochi SL, Thompson KM, et al
Updated characterization of poliovirus transmission in Pakistan and Afghanistan and the impacts of different outbreak response vaccine options.
J Infect Dis. 2021 Apr 22. pii: 6246102. doi: 10.1093.
PubMed Abstract available

KALA S, Meteleva K, Serghides L
ACE2, TMPRSS2 and L-SIGN expression in placentae from HIV-positive pregnancies exposed to antiretroviral therapy-implications for SARS-CoV-2 placental infection.
J Infect Dis. 2021 Apr 21. pii: 6242371. doi: 10.1093.
PubMed Abstract available

MCCARTNEY MM, Linderholm AL, Yamaguchi MS, Falcon AK, et al
Predicting influenza and rhinovirus infections in airway cells utilizing volatile emissions.
J Infect Dis. 2021 Apr 15. pii: 6226913. doi: 10.1093.
PubMed Abstract available

EL SAHLY HM, Atmar RL, Sendra E, Wegel A, et al
Topical Imiquimod Does not Provide an Adjuvant Effect when Administered with Inactivated Influenza A/H5N1 Vaccine in Healthy Young Adults.
J Infect Dis. 2021 Apr 14. pii: 6225864. doi: 10.1093.
PubMed Abstract available

SATO M, Takashita E, Katayose M, Nemoto K, et al
Detection of variants with reduced baloxavir marboxil and oseltamivir susceptibility in children with influenza A during the 2019-2020 influenza season.
J Infect Dis. 2021 Apr 10. pii: 6219607. doi: 10.1093.
PubMed Abstract available

ABBOUD H
Encephalitis in the Setting of COVID-19 Infection.
J Infect Dis. 2021;223:1303.
PubMed

TJAN LH, Furukawa K, Nagano T, Kiriu T, et al
Early Differences in Cytokine Production by Severity of Coronavirus Disease 2019.
J Infect Dis. 2021;223:1145-1149.
PubMed Abstract available

RATHE JA, Hemann EA, Eggenberger J, Li Z, et al
SARS-CoV-2 Serologic Assays in Control and Unknown Populations Demonstrate the Necessity of Virus Neutralization Testing.
J Infect Dis. 2021;223:1120-1131.
PubMed Abstract available

EISINGER RW, Lerner AM, Fauci AS
HIV/AIDS in the Era of COVID-19: A Juxtaposition of Two Pandemics.
J Infect Dis. 2021 Apr 7. pii: 6167835. doi: 10.1093.
PubMed Abstract available

March 2021

LAMARCA JH, de Carvalho FG, Machado FC, Lacerda-Santos R, et al
Severe Acute Respiratory Syndrome Coronavirus 2: A Protocol for Disinfection of Toothbrushes.
J Infect Dis. 2021;223:1113-1114.
PubMed

KLINGLER J, Weiss S, Itri V, Liu X, et al
Role of Immunoglobulin M and A Antibodies in the Neutralization of Severe Acute Respiratory Syndrome Coronavirus 2.
J Infect Dis. 2021;223:957-970.
PubMed Abstract available

HUGHES EC, Amat JAR, Haney J, Parr YA, et al
Severe Acute Respiratory Syndrome Coronavirus 2 Serosurveillance in a Patient Population Reveals Differences in Virus Exposure and Antibody-Mediated Immunity According to Host Demography and Healthcare Setting.
J Infect Dis. 2021;223:971-980.
PubMed Abstract available

STRICH JR, Ramos-Benitez MJ, Randazzo D, Stein SR, et al
Fostamatinib Inhibits Neutrophils Extracellular Traps Induced by COVID-19 Patient Plasma: A Potential Therapeutic.
J Infect Dis. 2021;223:981-984.
PubMed Abstract available

IZURIETA HS, Graham DJ, Jiao Y, Hu M, et al
Natural History of Coronavirus Disease 2019: Risk Factors for Hospitalizations and Deaths Among >26 Million US Medicare Beneficiaries.
J Infect Dis. 2021;223:945-956.
PubMed Abstract available

PETITO E, Falcinelli E, Paliani U, Cesari E, et al
Association of Neutrophil Activation, More Than Platelet Activation, With Thrombotic Complications in Coronavirus Disease 2019.
J Infect Dis. 2021;223:933-944.
PubMed Abstract available

NICOLAS DE LAMBALLERIE C, Pizzorno A, Dubois J, Padey B, et al
Human Respiratory Syncytial Virus-Induced Immune Signature of Infection Revealed by Transcriptome Analysis of Clinical Pediatric Nasopharyngeal Swab Samples.
J Infect Dis. 2021;223:1052-1061.
PubMed Abstract available

JORDAN E, Lawrence SJ, Meyer TPH, Schmidt D, et al
Broad Antibody and Cellular Immune Response From a Phase 2 Clinical Trial With a Novel Multivalent Poxvirus-Based Respiratory Syncytial Virus Vaccine.
J Infect Dis. 2021;223:1062-1072.
PubMed Abstract available

LAMOTH F, Lewis RE, Walsh TJ, Kontoyiannis DP, et al
Navigating the uncertainties of COVID-19 associated aspergillosis (CAPA): A comparison with influenza associated aspergillosis (IAPA).
J Infect Dis. 2021 Mar 26. pii: 6189669. doi: 10.1093.
PubMed Abstract available

LEWNARD JA, Bruxvoort KJ, Fischer H, Hong VX, et al
Prevention of COVID-19 among older adults receiving pneumococcal conjugate vaccine suggests interactions between Streptococcus pneumoniae and SARS-CoV-2 in the respiratory tract.
J Infect Dis. 2021 Mar 9. pii: 6164926. doi: 10.1093.
PubMed Abstract available

MCBRIDE DS, Perofsky AC, Nolting JM, Nelson MI, et al
Tracing the source of influenza A virus zoonoses in interconnected circuits of swine exhibitions.
J Infect Dis. 2021 Mar 4. pii: 6158869. doi: 10.1093.
PubMed Abstract available

BHATNAGAR J, Gary J, Reagan-Steiner S, Estetter LB, et al
Evidence of Severe Acute Respiratory Syndrome Coronavirus 2 Replication and Tropism in the Lungs, Airways, and Vascular Endothelium of Patients With Fatal Coronavirus Disease 2019: An Autopsy Case Series.
J Infect Dis. 2021;223:752-764.
PubMed Abstract available

GIRARDIN RC, Dupuis AP, Payne AF, Sullivan TJ, et al
Temporal Analysis of Serial Donations Reveals Decrease in Neutralizing Capacity and Justifies Revised Qualifying Criteria for Coronavirus Disease 2019 Convalescent Plasma.
J Infect Dis. 2021;223:743-751.
PubMed Abstract available

BLOCH EM, Crowe EP, Tobian AAR
Coronavirus Disease 2019 Convalescent Plasma and the Severe Acute Respiratory Syndrome Coronavirus 2 Neutralizing Titer.
J Infect Dis. 2021;223:740-742.
PubMed

ZHENG J, Wang Y, Li K, Meyerholz DK, et al
Severe Acute Respiratory Syndrome Coronavirus 2-Induced Immune Activation and Death of Monocyte-Derived Human Macrophages and Dendritic Cells.
J Infect Dis. 2021;223:785-795.
PubMed Abstract available

KLUMPP-THOMAS C, Kalish H, Hicks J, Mehalko J, et al
Effect of D614G Spike Variant on Immunoglobulin G, M, or A Spike Seroassay Performance.
J Infect Dis. 2021;223:802-804.
PubMed Abstract available

BOWMAN ER, Cameron CMA, Avery A, Gabriel J, et al
Levels of Soluble CD14 and Tumor Necrosis Factor Receptors 1 and 2 May Be Predictive of Death in Severe Coronavirus Disease 2019.
J Infect Dis. 2021;223:805-810.
PubMed Abstract available

RIEDER M, Wirth L, Pollmeier L, Jeserich M, et al
Serum Protein Profiling Reveals a Specific Upregulation of the Immunomodulatory Protein Progranulin in Coronavirus Disease 2019.
J Infect Dis. 2021;223:775-784.
PubMed Abstract available

JAHRSDORFER B, Kroschel J, Ludwig C, Corman VM, et al
Independent Side-by-Side Validation and Comparison of 4 Serological Platforms for SARS-CoV-2 Antibody Testing.
J Infect Dis. 2021;223:796-801.
PubMed Abstract available

CHATZIDIMITRIOU M, Chatzopoulou F, Gavriilaki E, Chatzivasileiou P, et al
Repeated Negative Serological Testing in Otherwise Healthy Patients With Coronavirus Disease 2019.
J Infect Dis. 2021;223:924-926.
PubMed

CODY MEISSNER H
Approaching the End of the Era of Uncontrolled Respiratory Syncytial Virus Disease.
J Infect Dis. 2021;223:737-739.
PubMed

THOMAS E, Mattila JM, Lehtinen P, Vuorinen T, et al
Burden of Respiratory Syncytial Virus Infection During the First Year of Life.
J Infect Dis. 2021;223:811-817.
PubMed Abstract available

CHORENO-PARRA JA, Jimenez-Alvarez LA, Ramirez-Martinez G, Cruz-Lagunas A, et al
Expression of Surfactant protein D (SP-D) distinguishes severe pandemic influenza A(H1N1) from COVID-19.
J Infect Dis. 2021 Mar 1. pii: 6154795. doi: 10.1093.
PubMed Abstract available

February 2021

BULFONE TC, Malekinejad M, Rutherford GW, Razani N, et al
Outdoor Transmission of SARS-CoV-2 and Other Respiratory Viruses: A Systematic Review.
J Infect Dis. 2021;223:550-561.
PubMed Abstract available

LERSY F, Benotmane I, Helms J, Collange O, et al
Cerebrospinal Fluid Features in Patients With Coronavirus Disease 2019 and Neurological Manifestations: Correlation with Brain Magnetic Resonance Imaging Findings in 58 Patients.
J Infect Dis. 2021;223:600-609.
PubMed Abstract available

TRIEU MC, Bansal A, Madsen A, Zhou F, et al
SARS-CoV-2-Specific Neutralizing Antibody Responses in Norwegian Health Care Workers After the First Wave of COVID-19 Pandemic: A Prospective Cohort Study.
J Infect Dis. 2021;223:589-599.
PubMed Abstract available

SINHA P, Jafarzadeh SR, Assoumou SA, Bielick CG, et al
The Effect of IL-6 Inhibitors on Mortality Among Hospitalized COVID-19 Patients: A Multicenter Study.
J Infect Dis. 2021;223:581-588.
PubMed Abstract available

BEDIN AS, Makinson A, Picot MC, Mennechet F, et al
Monocyte CD169 Expression as a Biomarker in the Early Diagnosis of Coronavirus Disease 2019.
J Infect Dis. 2021;223:562-567.
PubMed Abstract available

LI A, Ling Y, Song Z, Cheng X, et al
Correlation Between Early Plasma Interleukin 37 Responses With Low Inflammatory Cytokine Levels and Benign Clinical Outcomes in Severe Acute Respiratory Syndrome Coronavirus 2 Infection.
J Infect Dis. 2021;223:568-580.
PubMed Abstract available

DAI M, Li H, Yan N, Huang J, et al
Long-term Survival of SARS-CoV-2 on Salmon as a Source for International Transmission.
J Infect Dis. 2021;223:537-539.
PubMed

MOHKHEDKAR M, Venigalla SSK, Janakiraman V
Autoantigens That May Explain Postinfection Autoimmune Manifestations in Patients With Coronavirus Disease 2019 Displaying Neurological Conditions.
J Infect Dis. 2021;223:536-537.
PubMed

MUECKSCH F, Wise H, Batchelor B, Squires M, et al
Longitudinal Serological Analysis and Neutralizing Antibody Levels in Coronavirus Disease 2019 Convalescent Patients.
J Infect Dis. 2021;223:389-398.
PubMed Abstract available

GOLDSTEIN E, Lipsitch M, Cevik M
On the Effect of Age on the Transmission of SARS-CoV-2 in Households, Schools, and the Community.
J Infect Dis. 2021;223:362-369.
PubMed Abstract available

LIM JT, Chew LZX, Choo ELW, Dickens BSL, et al
Increased Dengue Transmissions in Singapore Attributable to SARS-CoV-2 Social Distancing Measures.
J Infect Dis. 2021;223:399-402.
PubMed Abstract available

MAROSSY A, Rakowicz S, Bhan A, Noon S, et al
A Study of Universal Severe Acute Respiratory Syndrome Coronavirus 2 RNA Testing Among Residents and Staff in a Large Group of Care Homes in South London.
J Infect Dis. 2021;223:381-388.
PubMed Abstract available

GALANTI M, Shaman J
Direct Observation of Repeated Infections With Endemic Coronaviruses.
J Infect Dis. 2021;223:409-415.
PubMed Abstract available

BEHR MA, Divangahi M, Schurr E
Lessons From Bacille Calmette-Guerin for SARS-CoV-2 Vaccine Candidates.
J Infect Dis. 2021;223:189-191.
PubMed Abstract available

HARRIS BHL, Zuhair M, Di Giovannantonio M, Rosadas C, et al
Asymptomatic Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection in a Rehabilitation Facility: Evolution of the Presence of Nasopharyngeal SARS-CoV-2 and Serological Antibody Responses.
J Infect Dis. 2021;223:192-196.
PubMed Abstract available

BRANDSMA E, Verhagen HJMP, van de Laar TJW, Claas ECJ, et al
Rapid, Sensitive, and Specific Severe Acute Respiratory Syndrome Coronavirus 2 Detection: A Multicenter Comparison Between Standard Quantitative Reverse-Transcriptase Polymerase Chain Reaction and CRISPR-Based DETECTR.
J Infect Dis. 2021;223:206-213.
PubMed Abstract available

CRAWFORD KHD, Dingens AS, Eguia R, Wolf CR, et al
Dynamics of Neutralizing Antibody Titers in the Months After Severe Acute Respiratory Syndrome Coronavirus 2 Infection.
J Infect Dis. 2021;223:197-205.
PubMed Abstract available

DE NOOIJER AH, Grondman I, Janssen NAF, Netea MG, et al
Complement Activation in the Disease Course of Coronavirus Disease 2019 and Its Effects on Clinical Outcomes.
J Infect Dis. 2021;223:214-224.
PubMed Abstract available

MANSBACH JM, Geller RJ, Hasegawa K, Piedra PA, et al
Detection of Respiratory Syncytial Virus or Rhinovirus Weeks After Hospitalization for Bronchiolitis and the Risk of Recurrent Wheezing.
J Infect Dis. 2021;223:268-277.
PubMed Abstract available

January 2021

JENNESS SM, Le Guillou A, Chandra C, Mann LM, et al
Projected HIV and Bacterial STI Incidence Following COVID-Related Sexual Distancing and Clinical Service Interruption.
J Infect Dis. 2021 Jan 28. pii: 6122459. doi: 10.1093.
PubMed Abstract available

EATON EF, Clement ME
Wave the Yellow Flag: Why we should prioritize routine HIV and STI care now.
J Infect Dis. 2021 Jan 27. pii: 6121541. doi: 10.1093.
PubMed

SUNTARATTIWONG P, Mott JA, Mohanty S, Sinthuwattanawibool C, et al
The feasibility and performance of participant-collected mid-turbinate nasal swabs for detection of influenza virus, respiratory syncytial virus, and human metapneumovirus infections among pregnant women.
J Infect Dis. 2021 Jan 18. pii: 6103926. doi: 10.1093.
PubMed Abstract available

BUI CHT, Yeung HW, Ho JCW, Leung CYH, et al
Tropism of SARS-CoV-2, SARS-CoV and influenza virus in canine tissue explants.
J Infect Dis. 2021 Jan 4. pii: 6062634. doi: 10.1093.
PubMed Abstract available

LI L, Huang M, Shen J, Wang Y, et al
Serum Levels of Soluble Platelet Endothelial Cell Adhesion Molecule 1 in COVID-19 Patients Are Associated With Disease Severity.
J Infect Dis. 2021;223:178-179.
PubMed

MONCUNILL G, Mayor A, Santano R, Jimenez A, et al
SARS-CoV-2 Seroprevalence and Antibody Kinetics Among Health Care Workers in a Spanish Hospital After 3 Months of Follow-up.
J Infect Dis. 2021;223:62-71.
PubMed Abstract available

HENSS L, Scholz T, von Rhein C, Wieters I, et al
Analysis of Humoral Immune Responses in Patients With Severe Acute Respiratory Syndrome Coronavirus 2 Infection.
J Infect Dis. 2021;223:56-61.
PubMed Abstract available

LEE WT, Girardin RC, Dupuis AP, Kulas KE, et al
Neutralizing Antibody Responses in COVID-19 Convalescent Sera.
J Infect Dis. 2021;223:47-55.
PubMed Abstract available

SUN H, Jain A, Leone MJ, Alabsi HS, et al
CoVA: An Acuity Score for Outpatient Screening that Predicts Coronavirus Disease 2019 Prognosis.
J Infect Dis. 2021;223:38-46.
PubMed Abstract available

BAANG JH, Smith C, Mirabelli C, Valesano AL, et al
Prolonged Severe Acute Respiratory Syndrome Coronavirus 2 Replication in an Immunocompromised Patient.
J Infect Dis. 2021;223:23-27.
PubMed Abstract available

ZHU J, Wu C, Wu L
Associations Between Genetically Predicted Protein Levels and COVID-19 Severity.
J Infect Dis. 2021;223:19-22.
PubMed Abstract available

YILMAZ A, Marklund E, Andersson M, Nilsson S, et al
Upper Respiratory Tract Levels of Severe Acute Respiratory Syndrome Coronavirus 2 RNA and Duration of Viral RNA Shedding Do Not Differ Between Patients With Mild and Severe/Critical Coronavirus Disease 2019.
J Infect Dis. 2021;223:15-18.
PubMed Abstract available

PATI A, Padhi S, Suvankar S, Panda AK, et al
Minor Allele of Interferon-Induced Transmembrane Protein 3 Polymorphism (rs12252) Is Covered Against Severe Acute Respiratory Syndrome Coronavirus 2 Infection and Mortality: A Worldwide Epidemiological Investigation.
J Infect Dis. 2021;223:175-178.
PubMed

KIDDE J, Sahebkar A
From Foe to Friend in COVID-19: Renin-Angiotensin System Inhibitors.
J Infect Dis. 2021;223:174-175.
PubMed

HICKS SM, Pohl K, Neeman T, McNamara HA, et al
A Dual-Antigen Enzyme-Linked Immunosorbent Assay Allows the Assessment of Severe Acute Respiratory Syndrome Coronavirus 2 Antibody Seroprevalence in a Low-Transmission Setting.
J Infect Dis. 2021;223:10-14.
PubMed Abstract available

PILOTTO A, Masciocchi S, Volonghi I, Crabbio M, et al
Clinical Presentation and Outcomes of Severe Acute Respiratory Syndrome Coronavirus 2-Related Encephalitis: The ENCOVID Multicenter Study.
J Infect Dis. 2021;223:28-37.
PubMed Abstract available

PILAROWSKI G, Lebel P, Sunshine S, Liu J, et al
Performance characteristics of a rapid SARS-CoV-2 antigen detection assay at a public plaza testing site in San Francisco.
J Infect Dis. 2021 Jan 4. pii: 6061974. doi: 10.1093.
PubMed Abstract available

TONG M, Zheng Q, Zhu Y
Reply to Li et al.
J Infect Dis. 2021;223:179-180.
PubMed

LEMPAINEN J, Korhonen LS, Kantojarvi K, Heinonen S, et al
Associations Between IFI44L Gene Variants and Rates of Respiratory Tract Infections During Early Childhood.
J Infect Dis. 2021;223:157-165.
PubMed Abstract available

MALTEZOU HC, Raftopoulos V, Vorou R, Papadima K, et al
Association between upper respiratory tract viral load, comorbidities, disease severity and outcome of patients with SARS-CoV-2 infection.
J Infect Dis. 2021 Jan 3. pii: 6060070. doi: 10.1093.
PubMed Abstract available

December 2020

TENFORDE MW, Talbot HK, Trabue CH, Gaglani M, et al
Influenza vaccine effectiveness against hospitalization in the United States, 2019-2020.
J Infect Dis. 2020 Dec 30. pii: 6055595. doi: 10.1093.
PubMed Abstract available

KUBALE J, Balmaseda A, Sanchez N, Lopez R, et al
Pneumonia following symptomatic influenza infection among Nicaraguan children before and after introduction of the pneumococcal conjugate vaccine.
J Infect Dis. 2020 Dec 22. pii: 6044070. doi: 10.1093.
PubMed Abstract available

KIMBALL J, Zhu Y, Wyatt D, Trabue CH, et al
Influenza Vaccine Failure Associated with Age and Immunosuppression.
J Infect Dis. 2020 Dec 19. pii: 6041867. doi: 10.1093.
PubMed Abstract available

FERDINANDS JM, Gaglani M, Ghamande S, Martin ET, et al
Vaccine effectiveness against influenza-associated hospitalizations among adults, 2018-2019, US Hospitalized Adult Influenza Vaccine Effectiveness Network.
J Infect Dis. 2020 Dec 18. pii: 6041424. doi: 10.1093.
PubMed Abstract available

November 2020

CLEMENS EA, Holbrook BC, Kanekiyo M, Yewdell JW, et al
An R848 conjugated influenza virus vaccine elicits robust IgG to hemagglutinin stem in a newborn nonhuman primate model.
J Infect Dis. 2020 Nov 27. pii: 6007684. doi: 10.1093.
PubMed Abstract available

TAN TQ, Kullar R, Swartz TH, Mathew TA, et al
Location Matters: Geographic Disparities and Impact of Coronavirus Disease 2019.
J Infect Dis. 2020;222:1951-1954.
PubMed Abstract available

SCHWAIGER J, Karbiener M, Aberham C, Farcet MR, et al
No SARS-CoV-2 Neutralization by Intravenous Immunoglobulins Produced From Plasma Collected Before the 2020 Pandemic.
J Infect Dis. 2020;222:1960-1964.
PubMed Abstract available

VITTE J, Diallo AB, Boumaza A, Lopez A, et al
A Granulocytic Signature Identifies COVID-19 and Its Severity.
J Infect Dis. 2020;222:1985-1996.
PubMed Abstract available

BENNER SE, Patel EU, Laeyendecker O, Pekosz A, et al
SARS-CoV-2 Antibody Avidity Responses in COVID-19 Patients and Convalescent Plasma Donors.
J Infect Dis. 2020;222:1974-1984.
PubMed Abstract available

NARANBHAI V, Chang CC, Beltran WFG, Miller TE, et al
High Seroprevalence of Anti-SARS-CoV-2 Antibodies in Chelsea, Massachusetts.
J Infect Dis. 2020;222:1955-1959.
PubMed Abstract available

GNIFFKE EP, Harrington WE, Dambrauskas N, Jiang Y, et al
Plasma From Recovered COVID-19 Patients Inhibits Spike Protein Binding to ACE2 in a Microsphere-Based Inhibition Assay.
J Infect Dis. 2020;222:1965-1973.
PubMed Abstract available

SCHIEFFELIN JS
Infectious Disease Outbreaks: The Need For an All-in Approach.
J Infect Dis. 2020;222:1941-1942.
PubMed

FALASCA L, Nardacci R, Colombo D, Lalle E, et al
Postmortem Findings in Italian Patients With COVID-19: A Descriptive Full Autopsy Study of Cases With and Without Comorbidities.
J Infect Dis. 2020;222:1807-1815.
PubMed Abstract available

BINDER RA, Alarja NA, Robie ER, Kochek KE, et al
Environmental and Aerosolized Severe Acute Respiratory Syndrome Coronavirus 2 Among Hospitalized Coronavirus Disease 2019 Patients.
J Infect Dis. 2020;222:1798-1806.
PubMed Abstract available

STERLING RK, Oakes T, Gal TS, Stevens MP, et al
The Fibrosis-4 Index Is Associated With Need for Mechanical Ventilation and 30-Day Mortality in Patients Admitted With Coronavirus Disease 2019.
J Infect Dis. 2020;222:1794-1797.
PubMed Abstract available

GUERVILLY C, Burtey S, Sabatier F, Cauchois R, et al
Circulating Endothelial Cells as a Marker of Endothelial Injury in Severe COVID -19.
J Infect Dis. 2020;222:1789-1793.
PubMed Abstract available

ZOU Y, Wang BR, Sun L, Xu S, et al
The Issue of Recurrently Positive Patients Who Recovered From COVID-19 According to the Current Discharge Criteria: Investigation of Patients from Multiple Medical Institutions in Wuhan, China.
J Infect Dis. 2020;222:1784-1788.
PubMed Abstract available

FJELLTVEIT EB, Cox RJ, Ostensjo J, Blomberg B, et al
Point-of-care influenza testing impacts clinical decision, patient flow and length of stay in hospitalized adults.
J Infect Dis. 2020 Nov 5. pii: 5957176. doi: 10.1093.
PubMed Abstract available

MARTIN ET, Cheng C, Petrie JG, Alyanak E, et al
Low influenza vaccine effectiveness against A(H3N2) associated hospitalizations in the 2016-2017 and 2017-2018 seasons of the Hospitalized Adult Influenza Vaccine Effectiveness Network (HAIVEN).
J Infect Dis. 2020 Nov 3. pii: 5952469. doi: 10.1093.
PubMed Abstract available

SALMON DA, Dudley MZ, Carleton BC
Guillain-Barre Syndrome Following Influenza Vaccines Affords Opportunity to Improve Vaccine Confidence.
J Infect Dis. 2020 Nov 2. pii: 5952166. doi: 10.1093.
PubMed

PEREZ-VILAR S, Hu M, Weintraub E, Arya D, et al
Guillain-Barre Syndrome After High-Dose Influenza Vaccine Administration in the United States, 2018-2019 Season.
J Infect Dis. 2020 Nov 2. pii: 5952165. doi: 10.1093.
PubMed Abstract available

October 2020

WANG W, Chen X, Wang Y, Lai S, et al
Serological evidence of human infection with avian influenza A(H7N9) virus: a systematic review and meta-analysis.
J Infect Dis. 2020 Oct 29. pii: 5943032. doi: 10.1093.
PubMed Abstract available

HINOJOSA M, Shepard SS, Chung JR, King JP, et al
Impact of Immune Priming, Vaccination and Infection on Influenza A(H3N2) Antibody Landscapes in Children.
J Infect Dis. 2020 Oct 22. pii: 5934948. doi: 10.1093.
PubMed Abstract available

MANCINI F, Barbanti F, Scaturro M, Fontana S, et al
Multiplex rt-Real Time PCR assays for diagnostic testing of SARS-CoV-2 and seasonal influenza viruses. A challenge of the phase 3 pandemic setting.
J Infect Dis. 2020 Oct 20. pii: 5932324. doi: 10.1093.
PubMed Abstract available

SHANNON I, White CL, Yang H, Nayak JL, et al
Differences in influenza-specific CD4 T cell mediated immunity following acute infection versus inactivated vaccination in children.
J Infect Dis. 2020 Oct 19. pii: 5930368. doi: 10.1093.
PubMed Abstract available

WEISS S, Klingler J, Hioe C, Amanat F, et al
A High-Throughput Assay for Circulating Antibodies Directed Against the S Protein of Severe Acute Respiratory Syndrome Coronavirus 2.
J Infect Dis. 2020;222:1629-1634.
PubMed Abstract available

SAUCEDA JA, Neilands TB, Lightfoot M, Saberi P, et al
Findings From a Probability-Based Survey of United States Households About Prevention Measures Based on Race, Ethnicity, and Age in Response to Severe Acute Respiratory Syndrome Coronavirus 2.
J Infect Dis. 2020;222:1607-1611.
PubMed Abstract available

SUGANO N, Ando W, Fukushima W
Cluster of Severe Acute Respiratory Syndrome Coronavirus 2 Infections Linked to Music Clubs in Osaka, Japan.
J Infect Dis. 2020;222:1635-1640.
PubMed Abstract available

BRADFUTE SB, Hurwitz I, Yingling AV, Ye C, et al
Severe Acute Respiratory Syndrome Coronavirus 2 Neutralizing Antibody Titers in Convalescent Plasma and Recipients in New Mexico: An Open Treatment Study in Patients With Coronavirus Disease 2019.
J Infect Dis. 2020;222:1620-1628.
PubMed Abstract available

KOO BS, Oh H, Kim G, Hwang EH, et al
Transient Lymphopenia and Interstitial Pneumonia With Endotheliitis in SARS-CoV-2-Infected Macaques.
J Infect Dis. 2020;222:1596-1600.
PubMed Abstract available

LURIE MN, Silva J, Yorlets RR, Tao J, et al
Coronavirus Disease 2019 Epidemic Doubling Time in the United States Before and During Stay-at-Home Restrictions.
J Infect Dis. 2020;222:1601-1606.
PubMed Abstract available

LAI CKC, Chen Z, Lui G, Ling L, et al
Prospective Study Comparing Deep Throat Saliva With Other Respiratory Tract Specimens in the Diagnosis of Novel Coronavirus Disease 2019.
J Infect Dis. 2020;222:1612-1619.
PubMed Abstract available

SHI T, Arnott A, Semogas I, Falsey AR, et al
The Etiological Role of Common Respiratory Viruses in Acute Respiratory Infections in Older Adults: A Systematic Review and Meta-analysis.
J Infect Dis. 2020;222.
PubMed Abstract available

MILLER M
Establishing the Value and Strategies for Respiratory Syncytial Virus (RSV) Control: The European RSV Consortium (RESCEU).
J Infect Dis. 2020;222.
PubMed

REEVES RM, van Wijhe M, Tong S, Lehtonen T, et al
Respiratory Syncytial Virus-Associated Hospital Admissions in Children Younger Than 5 Years in 7 European Countries Using Routinely Collected Datasets.
J Infect Dis. 2020;222.
PubMed Abstract available

LI Y, Campbell H, Nair H
Unveiling the Risk Period for Death After Respiratory Syncytial Virus Illness in Young Children Using a Self-Controlled Case Series Design.
J Infect Dis. 2020;222.
PubMed Abstract available

WILDENBEEST JG, Zuurbier RP, Korsten K, van Houten MA, et al
Respiratory Syncytial Virus Consortium in Europe (RESCEU) Birth Cohort Study: Defining the Burden of Infant Respiratory Syncytial Virus Disease in Europe.
J Infect Dis. 2020;222.
PubMed Abstract available

JEFFERIES K, Drysdale SB, Robinson H, Clutterbuck EA, et al
Presumed Risk Factors and Biomarkers for Severe Respiratory Syncytial Virus Disease and Related Sequelae: Protocol for an Observational Multicenter, Case-Control Study From the Respiratory Syncytial Virus Consortium in Europe (RESCEU).
J Infect Dis. 2020;222.
PubMed Abstract available

CHUNG A, Reeves RM, Nair H, Campbell H, et al
Hospital Admission Trends for Bronchiolitis in Scotland, 2001-2016: A National Retrospective Observational Study.
J Infect Dis. 2020;222.
PubMed Abstract available

ONER D, Drysdale SB, McPherson C, Lin GL, et al
Biomarkers for Disease Severity in Children Infected With Respiratory Syncytial Virus: A Systematic Literature Review.
J Infect Dis. 2020;222.
PubMed Abstract available

LIN GL, Golubchik T, Drysdale S, O'Connor D, et al
Simultaneous Viral Whole-Genome Sequencing and Differential Expression Profiling in Respiratory Syncytial Virus Infection of Infants.
J Infect Dis. 2020;222.
PubMed Abstract available

ZUURBIER RP, Bont LJ, Langedijk AC, Hamer M, et al
Low Sensitivity of BinaxNOW RSV in Infants.
J Infect Dis. 2020;222.
PubMed Abstract available

WISEMAN DJ, Thwaites RS, Drysdale SB, Janet S, et al
Immunological and Inflammatory Biomarkers of Susceptibility and Severity in Adult Respiratory Syncytial Virus Infections.
J Infect Dis. 2020;222.
PubMed Abstract available

ZHANG S, Akmar LZ, Bailey F, Rath BA, et al
Cost of Respiratory Syncytial Virus-Associated Acute Lower Respiratory Infection Management in Young Children at the Regional and Global Level: A Systematic Review and Meta-Analysis.
J Infect Dis. 2020;222.
PubMed Abstract available

CHAW PS, Hua L, Cunningham S, Campbell H, et al
Respiratory Syncytial Virus-Associated Acute Lower Respiratory Infections in Children With Bronchopulmonary Dysplasia: Systematic Review and Meta-Analysis.
J Infect Dis. 2020;222.
PubMed Abstract available

CHAW PS, Wong SWL, Cunningham S, Campbell H, et al
Acute Lower Respiratory Infections Associated With Respiratory Syncytial Virus in Children With Underlying Congenital Heart Disease: Systematic Review and Meta-analysis.
J Infect Dis. 2020;222.
PubMed Abstract available

SHI T, Ooi Y, Zaw EM, Utjesanovic N, et al
Association Between Respiratory Syncytial Virus-Associated Acute Lower Respiratory Infection in Early Life and Recurrent Wheeze and Asthma in Later Childhood.
J Infect Dis. 2020;222.
PubMed Abstract available

SHI T, Denouel A, Tietjen AK, Campbell I, et al
Global Disease Burden Estimates of Respiratory Syncytial Virus-Associated Acute Respiratory Infection in Older Adults in 2015: A Systematic Review and Meta-Analysis.
J Infect Dis. 2020;222.
PubMed Abstract available

LI D, Wolk DM, Cantor MN
Comparing Clinical Characteristics of Influenza and Common Coronavirus Infections using Electronic Health Records.
J Infect Dis. 2020 Oct 3. pii: 5917765. doi: 10.1093.
PubMed Abstract available

RABELO-DA-PONTE FD, Silvello D, Scherer JN, Ayala AR, et al
Convalescent Plasma Therapy in Patients With Severe or Life-Threatening COVID-19: A Metadata Analysis.
J Infect Dis. 2020;222:1575-1578.
PubMed

DEN HARTOG G, Schepp RM, Kuijer M, GeurtsvanKessel C, et al
SARS-CoV-2-Specific Antibody Detection for Seroepidemiology: A Multiplex Analysis Approach Accounting for Accurate Seroprevalence.
J Infect Dis. 2020;222:1452-1461.
PubMed Abstract available

SCHIAFFINO MT, Di Natale M, Garcia-Martinez E, Navarro J, et al
Immunoserologic Detection and Diagnostic Relevance of Cross-Reactive Autoantibodies in Coronavirus Disease 2019 Patients.
J Infect Dis. 2020;222:1439-1443.
PubMed Abstract available

WANG W, Liu X, Wu S, Chen S, et al
Definition and Risks of Cytokine Release Syndrome in 11 Critically Ill COVID-19 Patients With Pneumonia: Analysis of Disease Characteristics.
J Infect Dis. 2020;222:1444-1451.
PubMed Abstract available

ZENG QL, Yu ZJ, Ji F
Reply to Rabelo-da-Ponte et al.
J Infect Dis. 2020;222:1578.
PubMed

HAYDEN FG, Whitley RJ
Respiratory Syncytial Virus Antivirals: Problems and Progress.
J Infect Dis. 2020;222:1417-1421.
PubMed

STRAY K, Perron M, Porter DP, Anderson F, et al
Drug Resistance Assessment Following Administration of Respiratory Syncytial Virus (RSV) Fusion Inhibitor Presatovir to Participants Experimentally Infected With RSV.
J Infect Dis. 2020;222:1468-1477.
PubMed Abstract available

September 2020

PENKERT RR, Smith AP, Hrincius ER, McCullers JA, et al
Vitamin A deficiency dysregulates immune responses toward influenza virus and increases mortality after bacterial coinfections.
J Infect Dis. 2020 Sep 22. pii: 5909831. doi: 10.1093.
PubMed Abstract available

ZHAO T
Interferon-Induced Transmembrane Protein 3 Related to Coronavirus Disease 2019.
J Infect Dis. 2020;222:1413.
PubMed

LI JZ, Yu XG
Overcoming Challenges in Coronavirus Disease 19 Translational Research.
J Infect Dis. 2020;222:1254-1255.
PubMed

LIU X, Tang J, Xie R, Li W, et al
Clinical and Epidemiological Features of 46 Children <1 Year Old With Coronavirus Disease 2019 in Wuhan, China: A Descriptive Study.
J Infect Dis. 2020;222:1293-1297.
PubMed Abstract available

BOND K, Nicholson S, Lim SM, Karapanagiotidis T, et al
Evaluation of Serological Tests for SARS-CoV-2: Implications for Serology Testing in a Low-Prevalence Setting.
J Infect Dis. 2020;222:1280-1288.
PubMed Abstract available

LEUZINGER K, Roloff T, Gosert R, Sogaard K, et al
Epidemiology of Severe Acute Respiratory Syndrome Coronavirus 2 Emergence Amidst Community-Acquired Respiratory Viruses.
J Infect Dis. 2020;222:1270-1279.
PubMed Abstract available

MEISTER TL, Bruggemann Y, Todt D, Conzelmann C, et al
Virucidal Efficacy of Different Oral Rinses Against Severe Acute Respiratory Syndrome Coronavirus 2.
J Infect Dis. 2020;222:1289-1292.
PubMed Abstract available

RIJKERS G, Murk JL, Wintermans B, van Looy B, et al
Differences in Antibody Kinetics and Functionality Between Severe and Mild Severe Acute Respiratory Syndrome Coronavirus 2 Infections.
J Infect Dis. 2020;222:1265-1269.
PubMed Abstract available

LAM KW, Chow KW, Vo J, Hou W, et al
Continued In-Hospital Angiotensin-Converting Enzyme Inhibitor and Angiotensin II Receptor Blocker Use in Hypertensive COVID-19 Patients Is Associated With Positive Clinical Outcome.
J Infect Dis. 2020;222:1256-1264.
PubMed Abstract available

FALSEY AR, Walsh EE
Respiratory Syncytial Virus: An Old Foe in a New Era.
J Infect Dis. 2020;222:1245-1246.
PubMed

TSENG HF, Sy LS, Ackerson B, Solano Z, et al
Severe Morbidity and Short- and Mid- to Long-term Mortality in Older Adults Hospitalized with Respiratory Syncytial Virus Infection.
J Infect Dis. 2020;222:1298-1310.
PubMed Abstract available

FILL MA
Multistate Outbreak of Seoul Virus: Implications for the One Health Movement and Pandemic Preparedness.
J Infect Dis. 2020;222:1247-1249.
PubMed

LEI H, Xu M, Wang X, Xie Y, et al
Non-pharmaceutical interventions used to control COVID-19 reduced seasonal influenza transmission in China.
J Infect Dis. 2020 Sep 8. pii: 5902938. doi: 10.1093.
PubMed Abstract available

HADLER JL
Will SARS-CoV-2 prevention efforts affect the coming influenza season in the United States and northern hemisphere?
J Infect Dis. 2020 Sep 7. pii: 5902575. doi: 10.1093.
PubMed

ZIMMERMAN RK, South-Paul JE, Poland GA
Rationing of civilian COVID-19 vaccines while supplies are limited.
J Infect Dis. 2020 Sep 7. pii: 5902567. doi: 10.1093.
PubMed

NALIN D
Immunosenescence and SARS-CoV-2 Vaccine Development.
J Infect Dis. 2020 Sep 5. pii: 5901694. doi: 10.1093.
PubMed

LI Y, Wang X, Nair H
Global Seasonality of Human Seasonal Coronaviruses: A Clue for Postpandemic Circulating Season of Severe Acute Respiratory Syndrome Coronavirus 2?
J Infect Dis. 2020;222:1090-1097.
PubMed Abstract available

SHOOK-SA BE, Boyce RM, Aiello AE
Estimation Without Representation: Early Severe Acute Respiratory Syndrome Coronavirus 2 Seroprevalence Studies and the Path Forward.
J Infect Dis. 2020;222:1086-1089.
PubMed Abstract available

HELLEBERG M, Niemann CU, Moestrup KS, Kirk O, et al
Persistent COVID-19 in an Immunocompromised Patient Temporarily Responsive to Two Courses of Remdesivir Therapy.
J Infect Dis. 2020;222:1103-1107.
PubMed Abstract available

YAMAGISHI T, Ohnishi M, Matsunaga N, Kakimoto K, et al
Environmental Sampling for Severe Acute Respiratory Syndrome Coronavirus 2 During a COVID-19 Outbreak on the Diamond Princess Cruise Ship.
J Infect Dis. 2020;222:1098-1102.
PubMed Abstract available

SIEDNER MJ, Gandhi RT, Kim AY
Desperate Times Call for Temperate Measures: Practicing Infectious Diseases During a Novel Pandemic.
J Infect Dis. 2020;222:1084-1085.
PubMed

OFMAN G, Pradarelli B, Caballero MT, Bianchi A, et al
Respiratory Failure and Death in Vulnerable Premature Children With Lower Respiratory Tract Illness.
J Infect Dis. 2020;222:1129-1137.
PubMed Abstract available

August 2020

TAKAHASHI S, Greenhouse B, Rodriguez-Barraquer I
Are SARS-CoV-2 seroprevalence estimates biased?
J Infect Dis. 2020 Aug 28. pii: 5898481. doi: 10.1093.
PubMed

SADOFF J, De Paepe E, Haazen W, Omoruyi E, et al
Safety and Immunogenicity of the Ad26.RSV.preF Investigational Vaccine Coadministered With an Influenza Vaccine in Older Adults.
J Infect Dis. 2020 Aug 26. pii: 5897745. doi: 10.1093.
PubMed Abstract available

HASFORD J
Large Simple Double-Blind Randomized Trials for the Rapid Assessment of the Effectiveness of COVID-19 Vaccines.
J Infect Dis. 2020 Aug 26. pii: 5897422. doi: 10.1093.
PubMed

VAN BOVEN M, Teirlinck AC, Meijer A, Hooiveld M, et al
Estimating Transmission Parameters for Respiratory Syncytial Virus and Predicting the Impact of Maternal and Pediatric Vaccination.
J Infect Dis. 2020 Aug 21. pii: 5895295. doi: 10.1093.
PubMed Abstract available

SHI D, Wu W, Wang Q, Xu K, et al
Clinical Characteristics and Factors Associated With Long-Term Viral Excretion in Patients With Severe Acute Respiratory Syndrome Coronavirus 2 Infection: a Single-Center 28-Day Study.
J Infect Dis. 2020;222:910-918.
PubMed Abstract available

KULLAR R, Marcelin JR, Swartz TH, Piggott DA, et al
Racial Disparity of Coronavirus Disease 2019 in African American Communities.
J Infect Dis. 2020;222:890-893.
PubMed Abstract available

PILCHER CD, Westreich D, Hudgens MG
Group Testing for Severe Acute Respiratory Syndrome- Coronavirus 2 to Enable Rapid Scale-up of Testing and Real-Time Surveillance of Incidence.
J Infect Dis. 2020;222:903-909.
PubMed Abstract available

TONG M, Jiang Y, Xia D, Xiong Y, et al
Elevated Expression of Serum Endothelial Cell Adhesion Molecules in COVID-19 Patients.
J Infect Dis. 2020;222:894-898.
PubMed Abstract available

HALSTEAD SB, Katzelnick L
COVID 19 Vaccines: Should we fear ADE?
J Infect Dis. 2020 Aug 12. pii: 5891764. doi: 10.1093.
PubMed Abstract available

PANG Y, Wang Q, Lv M, Yu M, et al
Influenza vaccination protects against hospitalization outcomes among older patients with cardiovascular or respiratory diseases.
J Infect Dis. 2020 Aug 11. pii: 5890841. doi: 10.1093.
PubMed Abstract available

GILCA R, Carazo S, Amini R, Charest H, et al
Common human coronaviruses seem at least as severe as influenza in patients hospitalized with acute respiratory infection: results from 8-year hospital-based surveillance in Quebec, Canada.
J Infect Dis. 2020 Aug 6. pii: 5882014. doi: 10.1093.
PubMed Abstract available

BALTRUSAITIS K, Reed C, Sewalk K, Brownstein JS, et al
Health-care seeking behavior for respiratory illness among Flu Near You participants in the United States during the 2015-16 through 2018-19 influenza season.
J Infect Dis. 2020 Aug 6. pii: 5881614. doi: 10.1093.
PubMed Abstract available

KANZAWA M, Spindler H, Anglemyer A, Rutherford GW, et al
Will Coronavirus Disease 2019 Become Seasonal?
J Infect Dis. 2020;222:719-721.
PubMed Abstract available

VOO TC, Clapham H, Tam CC
Ethical Implementation of Immunity Passports During the COVID-19 Pandemic.
J Infect Dis. 2020;222:715-718.
PubMed Abstract available

CHI Y, Ge Y, Wu B, Zhang W, et al
Serum Cytokine and Chemokine Profile in Relation to the Severity of Coronavirus Disease 2019 in China.
J Infect Dis. 2020;222:746-754.
PubMed Abstract available

IBANEZ-SAMANIEGO L, Bighelli F, Uson C, Caravaca C, et al
Elevation of Liver Fibrosis Index FIB-4 Is Associated With Poor Clinical Outcomes in Patients With COVID-19.
J Infect Dis. 2020;222:726-733.
PubMed Abstract available

YANG D, Chu H, Hou Y, Chai Y, et al
Attenuated Interferon and Proinflammatory Response in SARS-CoV-2-Infected Human Dendritic Cells Is Associated With Viral Antagonism of STAT1 Phosphorylation.
J Infect Dis. 2020;222:734-745.
PubMed Abstract available

CLEMENTI N, Ferrarese R, Criscuolo E, Diotti RA, et al
Interferon-beta-1a Inhibition of Severe Acute Respiratory Syndrome-Coronavirus 2 In Vitro When Administered After Virus Infection.
J Infect Dis. 2020;222:722-725.
PubMed Abstract available

WONG MCS, Huang J, Teoh JYC, Wong SH, et al
Identifying a Capability Framework That Could Mitigate the Coronavirus Disease 2019 Pandemic in a Global Health Community.
J Infect Dis. 2020;222:880-881.
PubMed

DOBRZYNSKI DM, Ndi DN, Zhu Y, Markus T, et al
Corrigendum to: Hospital Readmissions After Laboratory-Confirmed Influenza Hospitalization.
J Infect Dis. 2020 Aug 1. pii: 5879633. doi: 10.1093.
PubMed

July 2020

MACIAS GIL R, Marcelin JR, Zuniga-Blanco B, Marquez C, et al
COVID-19 Pandemic: Disparate Health Impact on the Hispanic/Latinx Population in the United States.
J Infect Dis. 2020 Jul 30. pii: 5878913. doi: 10.1093.
PubMed Abstract available

PANDA AK, Tripathy R, Das BK
Plasmodium falciparum infection may protect a population from SARS-CoV-2 infection.
J Infect Dis. 2020 Jul 29. pii: 5878042. doi: 10.1093.
PubMed

LI P, Liu J, Ma Z, Bramer WM, et al
Estimating Global Epidemiology of Low-Pathogenic Human Coronaviruses in Relation to the COVID-19 Context.
J Infect Dis. 2020;222:695-696.
PubMed

PINTO BGG, Oliveira AER, Singh Y, Jimenez L, et al
ACE2 Expression Is Increased in the Lungs of Patients With Comorbidities Associated With Severe COVID-19.
J Infect Dis. 2020;222:556-563.
PubMed Abstract available

SCHUIT M, Ratnesar-Shumate S, Yolitz J, Williams G, et al
Airborne SARS-CoV-2 Is Rapidly Inactivated by Simulated Sunlight.
J Infect Dis. 2020;222:564-571.
PubMed Abstract available

BAO L, Gao H, Deng W, Lv Q, et al
Transmission of Severe Acute Respiratory Syndrome Coronavirus 2 via Close Contact and Respiratory Droplets Among Human Angiotensin-Converting Enzyme 2 Mice.
J Infect Dis. 2020;222:551-555.
PubMed Abstract available

NICKBAKHSH S, Ho A, Marques DFP, McMenamin J, et al
Reply to Li et al.
J Infect Dis. 2020;222:696-698.
PubMed

TRICOCHE AD, Wagner AL, Balmaseda A, Sanchez N, et al
Symptoms, Infection Duration, and Hemagglutinin Inhibition Antibody Response in Influenza A Infections.
J Infect Dis. 2020 Jul 16. pii: 5872037. doi: 10.1093.
PubMed Abstract available

SCHLOM J, Donahue RN
Do Not Minimize the Impact of Cellular Immunity in the Development of Vaccines and Therapeutics for COVID-19.
J Infect Dis. 2020 Jul 11. pii: 5870046. doi: 10.1093.
PubMed

DAWSON L, Earl J, Livezey J
Severe Acute Respiratory Syndrome Coronavirus 2 Human Challenge Trials: Too Risky, Too Soon.
J Infect Dis. 2020;222:514-516.
PubMed

ZENG QL, Ji F, Zhang JY
Response to Malkovsky.
J Infect Dis. 2020;222:510-511.
PubMed

HAO S, Lian J, Lu Y, Jia H, et al
Decreased B Cells on Admission Associated With Prolonged Viral RNA Shedding From the Respiratory Tract in Coronavirus Disease 2019: A Case-Control Study.
J Infect Dis. 2020;222:367-371.
PubMed Abstract available

TRAUGOTT M, Aberle SW, Aberle JH, Griebler H, et al
Performance of Severe Acute Respiratory Syndrome Coronavirus 2 Antibody Assays in Different Stages of Infection: Comparison of Commercial Enzyme-Linked Immunosorbent Assays and Rapid Tests.
J Infect Dis. 2020;222:362-366.
PubMed Abstract available

LARGENT EA, Lynch HF
Paying Participants in COVID-19 Trials.
J Infect Dis. 2020;222:356-361.
PubMed Abstract available

MALKOVSKY M
Therapeutic Plasma Exchange-Neutralizing Antibody Combination Therapy for Severe Coronavirus Disease 2019.
J Infect Dis. 2020;222:509-510.
PubMed

DAVERIO M, Amigoni A, Cavicchiolo ME
Testing for Novel Coronavirus Antibodies: A Necessary Adjunct.
J Infect Dis. 2020;222:517-518.
PubMed

June 2020

O'NEIL B, Ison MG, Hallouin-Bernard MC, Nilsson AC, et al
A Phase 2 Study of Pimodivir (JNJ-63623872) in Combination with Oseltamivir in Elderly and NonElderly Adults Hospitalized with Influenza A Infection: OPAL study.
J Infect Dis. 2020 Jun 30. pii: 5865447. doi: 10.1093.
PubMed Abstract available

HO HE, Peluso MJ, Margus C, Matias Lopes JP, et al
Clinical outcomes and immunologic characteristics of Covid-19 in people with HIV.
J Infect Dis. 2020 Jun 30. pii: 5864898. doi: 10.1093.
PubMed Abstract available

LI L, Li X, Guo Z, Wang Z, et al
Influence of Storage Conditions on SARS-CoV-2 Nucleic Acid Detection in Throat Swabs.
J Infect Dis. 2020;222:203-205.
PubMed Abstract available

RATNESAR-SHUMATE S, Williams G, Green B, Krause M, et al
Simulated Sunlight Rapidly Inactivates SARS-CoV-2 on Surfaces.
J Infect Dis. 2020;222:214-222.
PubMed Abstract available

BURBELO PD, Riedo FX, Morishima C, Rawlings S, et al
Sensitivity in Detection of Antibodies to Nucleocapsid and Spike Proteins of Severe Acute Respiratory Syndrome Coronavirus 2 in Patients With Coronavirus Disease 2019.
J Infect Dis. 2020;222:206-213.
PubMed Abstract available

KOBAYASHI KI, Kaki T, Mizuno S, Kubo K, et al
Clinical Characteristics of Patients With Coronavirus Disease 2019 in Japan: A Single-Center Case Series.
J Infect Dis. 2020;222:194-197.
PubMed Abstract available

CAI XF, Chen J, Li Hu J, Long QX, et al
A Peptide-Based Magnetic Chemiluminescence Enzyme Immunoassay for Serological Diagnosis of Coronavirus Disease 2019.
J Infect Dis. 2020;222:189-193.
PubMed Abstract available

JIANG M, Guo Y, Luo Q, Huang Z, et al
T-Cell Subset Counts in Peripheral Blood Can Be Used as Discriminatory Biomarkers for Diagnosis and Severity Prediction of Coronavirus Disease 2019.
J Infect Dis. 2020;222:198-202.
PubMed Abstract available

ZHANG G, Nie S, Zhang Z, Zhang Z, et al
Longitudinal Change of Severe Acute Respiratory Syndrome Coronavirus 2 Antibodies in Patients with Coronavirus Disease 2019.
J Infect Dis. 2020;222:183-188.
PubMed Abstract available

SEPPALA EM, Oikarinen S, Lehtonen JP, Neupane S, et al
Association of Picornavirus Infections With Acute Otitis Media in a Prospective Birth Cohort Study.
J Infect Dis. 2020;222:324-332.
PubMed Abstract available

THIELEN BK, Bye E, Wang X, Maroushek S, et al
Summer Outbreak of Severe RSV-B Disease, Minnesota, 2017 Associated with Emergence of a Genetically Distinct Viral Lineage.
J Infect Dis. 2020;222:288-297.
PubMed Abstract available

UUSITUPA E, Waris M, Heikkinen T
Association of Viral Load With Disease Severity in Outpatient Children With Respiratory Syncytial Virus Infection.
J Infect Dis. 2020;222:298-304.
PubMed Abstract available

KINLOCH NN, Ritchie G, Brumme CJ, Dong W, et al
Suboptimal biological sampling as a probable cause of false-negative COVID-19 diagnostic test results.
J Infect Dis. 2020 Jun 28. pii: 5864227. doi: 10.1093.
PubMed Abstract available

JACKSON ML, Scott E, Kuypers J, Nalla AK, et al
Epidemiology of respiratory syncytial virus across five influenza seasons among adults and children one year of age and older - Washington State, 2011/12 - 2015/16.
J Infect Dis. 2020 Jun 19. pii: 5859587. doi: 10.1093.
PubMed Abstract available

MINTER A, Hoschler K, Jagne YJ, Sallah H, et al
Estimation of seasonal influenza attack rates and antibody dynamics in children using cross-sectional serological data.
J Infect Dis. 2020 Jun 18. pii: 5859586. doi: 10.1093.
PubMed Abstract available

ZHANG Y, Qin L, Zhao Y, Zhang P, et al
Interferon-Induced Transmembrane Protein 3 Genetic Variant rs12252-C Associated With Disease Severity in Coronavirus Disease 2019.
J Infect Dis. 2020;222:34-37.
PubMed Abstract available

ZENG QL, Yu ZJ, Gou JJ, Li GM, et al
Effect of Convalescent Plasma Therapy on Viral Shedding and Survival in Patients With Coronavirus Disease 2019.
J Infect Dis. 2020;222:38-43.
PubMed Abstract available

NIE X, Fan L, Mu G, Tan Q, et al
Epidemiological Characteristics and Incubation Period of 7015 Confirmed Cases With Coronavirus Disease 2019 Outside Hubei Province in China.
J Infect Dis. 2020;222:26-33.
PubMed Abstract available

NICKBAKHSH S, Ho A, Marques DFP, McMenamin J, et al
Epidemiology of Seasonal Coronaviruses: Establishing the Context for the Emergence of Coronavirus Disease 2019.
J Infect Dis. 2020;222:17-25.
PubMed Abstract available

MOORE HC, Lim FJ, Fathima P, Barnes R, et al
Assessing the Burden of Laboratory-Confirmed Respiratory Syncytial Virus Infection in a Population Cohort of Australian Children Through Record Linkage.
J Infect Dis. 2020;222:92-101.
PubMed Abstract available

MIDULLA F, Di Mattia G, Nenna R, Scagnolari C, et al
Novel Variants of Respiratory Syncytial Virus A ON1 Associated With Increased Clinical Severity of Bronchiolitis.
J Infect Dis. 2020;222:102-110.
PubMed Abstract available

JIANG XL, Zhang XL, Zhao XN, Li CB, et al
Transmission Potential of Asymptomatic and Paucisymptomatic Severe Acute Respiratory Syndrome Coronavirus 2 Infections: A 3-Family Cluster Study in China.
J Infect Dis. 2020;221:1948-1952.
PubMed Abstract available

PAN Y, Yu X, Du X, Li Q, et al
Epidemiological and Clinical Characteristics of 26 Asymptomatic Severe Acute Respiratory Syndrome Coronavirus 2 Carriers.
J Infect Dis. 2020;221:1940-1947.
PubMed Abstract available

ALLEN J
My Future in Medicine: How COVID-19 Is Inspiring the Next Generation of Infectious Disease Specialists.
J Infect Dis. 2020;221:1938-1939.
PubMed

URSIN RL, Liu H, Powell HR, Westerbeck J, et al
Differential antibody recognition of H3N2 vaccine and seasonal influenza virus strains based on age, vaccine status, and sex in the 2017-18 season.
J Infect Dis. 2020 Jun 4. pii: 5851359. doi: 10.1093.
PubMed Abstract available

SINGH JA
The case for why Africa should host COVID-19 candidate vaccine trials.
J Infect Dis. 2020 Jun 3. pii: 5850913. doi: 10.1093.
PubMed Abstract available

HOA LNM, Sullivan SG, Mai LQ, Khvorov A, et al
Influenza A(H1N1)pdm09 but not A(H3N2) virus infection induces durable sero-protection: results from the Ha Nam Cohort.
J Infect Dis. 2020 Jun 2. pii: 5850322. doi: 10.1093.
PubMed Abstract available

KANG CK, Kim HR, Song KH, Keam B, et al
Cell-Mediated Immunogenicity of Influenza Vaccination in Patients with Cancer Receiving Immune Checkpoint Inhibitors.
J Infect Dis. 2020 Jun 1. pii: 5849850. doi: 10.1093.
PubMed Abstract available

May 2020

ROBERTS NJ
Further discussion of a likely explanation for decreased peripheral blood anti-influenza CD8+ T cell activity during severe infection.
J Infect Dis. 2020 May 27. pii: 5847826. doi: 10.1093.
PubMed

FUKUYAMA S, Iwatsuki-Horimoto K, Kiso M, Nakajima N, et al
Pathogenesis of influenza A(H7N9) virus in aged non-human primates.
J Infect Dis. 2020 May 20. pii: 5841298. doi: 10.1093.
PubMed Abstract available

COWLING BJ, Thompson MG, Ng TWY, Fang VJ, et al
Comparative Reactogenicity of Enhanced Influenza Vaccines in Older Adults.
J Infect Dis. 2020 May 14. pii: 5837136. doi: 10.1093.
PubMed Abstract available

WANG F, Nie J, Wang H, Zhao Q, et al
Characteristics of Peripheral Lymphocyte Subset Alteration in COVID-19 Pneumonia.
J Infect Dis. 2020;221:1762-1769.
PubMed Abstract available

WANG Y, Liu Y, Liu L, Wang X, et al
Clinical Outcomes in 55 Patients With Severe Acute Respiratory Syndrome Coronavirus 2 Who Were Asymptomatic at Hospital Admission in Shenzhen, China.
J Infect Dis. 2020;221:1770-1774.
PubMed Abstract available

CUI Y, Tian M, Huang D, Wang X, et al
A 55-Day-Old Female Infant Infected With 2019 Novel Coronavirus Disease: Presenting With Pneumonia, Liver Injury, and Heart Damage.
J Infect Dis. 2020;221:1775-1781.
PubMed Abstract available

YU P, Zhu J, Zhang Z, Han Y, et al
A Familial Cluster of Infection Associated With the 2019 Novel Coronavirus Indicating Possible Person-to-Person Transmission During the Incubation Period.
J Infect Dis. 2020;221:1757-1761.
PubMed Abstract available

COWLING BJ, Aiello AE
Public Health Measures to Slow Community Spread of Coronavirus Disease 2019.
J Infect Dis. 2020;221:1749-1751.
PubMed

ZHANG N, Zhu L, Zhang Y, Zhou C, et al
Circulating rather than alveolar extracellular DNA levels predict outcomes in influenza.
J Infect Dis. 2020 May 10. pii: 5841516. doi: 10.1093.
PubMed Abstract available

BARTSCH SM, Mitgang EA, Geller G, Cox SN, et al
What if the Influenza Vaccine Did Not Offer Such Variable Protection?
J Infect Dis. 2020 May 9. pii: 5835317. doi: 10.1093.
PubMed Abstract available

TURNER JS, Lei T, Schmitz AJ, Day A, et al
Impaired Cellular Immune Responses During the First Week of Severe Acute Influenza Infection.
J Infect Dis. 2020 May 5. pii: 5830762. doi: 10.1093.
PubMed Abstract available

GRAEPEL KW, Kochhar S, Clayton EW, Edwards KE, et al
Balancing Expediency and Scientific Rigor in SARS-CoV-2 Vaccine Development.
J Infect Dis. 2020 May 4. pii: 5828933. doi: 10.1093.
PubMed

April 2020

CIOFFI A
COVID-19: Is Everything Appropriate to Create an Effective Vaccine?
J Infect Dis. 2020 Apr 29. pii: 5826955. doi: 10.1093.
PubMed

WILLIAMS K, Bastian AR, Feldman RA, Omoruyi E, et al
Phase 1 Safety and Immunogenicity Study of a Respiratory Syncytial Virus Vaccine with an Adenovirus 26 Vector Encoding Pre-Fusion F (Ad26.RSV.preF) in adults 60 years and older.
J Infect Dis. 2020 Apr 22. pii: 5823828. doi: 10.1093.
PubMed Abstract available

ACKERSON B, An J, Sy LS, Solano Z, et al
Cost of Hospitalization Associated with Respiratory Syncytial Virus Infection Versus Influenza Infection in Hospitalized Older Adults.
J Infect Dis. 2020 Apr 17. pii: 5821154. doi: 10.1093.
PubMed Abstract available

RYU S, Ali ST, Cowling BJ, Lau EHY, et al
Effects of school holidays on seasonal influenza in South Korea, 2014-2016.
J Infect Dis. 2020 Apr 11. pii: 5818974. doi: 10.1093.
PubMed Abstract available

MOHN KG, Brokstad KA, Islam S, Oftung F, et al
Early Induction of Cross-Reactive CD8+ T-Cell Responses in Tonsils After Live-Attenuated Influenza Vaccination in Children.
J Infect Dis. 2020;221:1528-1537.
PubMed Abstract available

INCE WL, Smith FB, O'Rear JJ, Thomson M, et al
Treatment-emergent influenza virus PA substitutions independent of those at I38 associated with reduced baloxavir susceptibility and virus rebound in trials of baloxavir marboxil.
J Infect Dis. 2020 Apr 7. pii: 5816798. doi: 10.1093.
PubMed Abstract available

SIEGERS JY, Novakovic B, Hulme KD, Marshall R, et al
A high fat diet increases influenza A virus-associated cardiovascular damage.
J Infect Dis. 2020 Apr 4. pii: 5815741. doi: 10.1093.
PubMed Abstract available

March 2020

EYAL N, Lipsitch M, Smith PG
Human challenge studies to accelerate coronavirus vaccine licensure.
J Infect Dis. 2020 Mar 31. pii: 5814216. doi: 10.1093.
PubMed Abstract available

SIMOES EAF, Chirikov V, Botteman M, Kwon Y, et al
Long-term Assessment of Healthcare Utilization 5 Years After Respiratory Syncytial Virus Infection in US Infants.
J Infect Dis. 2020;221:1256-1270.
PubMed Abstract available

PIEDRA PA
Long-Term Healthcare Costs Associated With Respiratory Syncytial Virus Infection in Children: The Domino Effect.
J Infect Dis. 2020;221:1205-1207.
PubMed

CHIRIKOV VV, Simoes EAF, Kuznik A, Kwon Y, et al
Economic-Burden Trajectories in Commercially Insured US Infants With Respiratory Syncytial Virus Infection.
J Infect Dis. 2020;221:1244-1255.
PubMed Abstract available

SKOWRONSKI DM, Leir S, Sabaiduc S, Chambers C, et al
Influenza vaccine effectiveness by A(H3N2) phylogenetic sub-cluster and prior vaccination history: 2016-17 and 2017-18 epidemics in Canada.
J Infect Dis. 2020 Mar 26. pii: 5811682. doi: 10.1093.
PubMed Abstract available

DOBRZYNSKI DM, Ndi DN, Zhu Y, Markus T, et al
Hospital Readmissions following Laboratory-confirmed Influenza Hospitalization.
J Infect Dis. 2020 Mar 17. pii: 5808013. doi: 10.1093.
PubMed Abstract available

FONG MW, Leung NHL, Xiao J, Chu DKW, et al
Presence of influenza virus on touch-surfaces in kindergartens and primary schools.
J Infect Dis. 2020 Mar 16. pii: 5807949. doi: 10.1093.
PubMed Abstract available

ZOU P, Wang C, Zheng S, Guo F, et al
Invasive Pulmonary Aspergillosis in Adults With Avian Influenza A (H7N9) Pneumonia in China: A Retrospective Study.
J Infect Dis. 2020;221.
PubMed Abstract available

PHILIPPON DAM, Wu P, Cowling BJ, Lau EHY, et al
Avian influenza human infections at the human-animal interface.
J Infect Dis. 2020 Mar 10. pii: 5802683. doi: 10.1093.
PubMed Abstract available

LEES C, Godin J, McElhaney JE, McNeil SA, et al
Frailty Hinders Recovery From Influenza and Acute Respiratory Illness in Older Adults.
J Infect Dis. 2020 Mar 9. pii: 5799273. doi: 10.1093.
PubMed

GRAHAM JB, Swarts JL, Menachery VD, Gralinski LE, et al
Immune Predictors of Mortality After Ribonucleic Acid Virus Infection.
J Infect Dis. 2020;221:882-889.
PubMed Abstract available

February 2020

IZURIETA HS, Chillarige Y, Kelman J, Wei Y, et al
Relative effectiveness of influenza vaccines among the U.S. elderly, 2018-19.
J Infect Dis. 2020 Feb 26. pii: 5758057. doi: 10.1093.
PubMed Abstract available

SATO M, Takashita E, Katayose M, Nemoto K, et al
Detection of variants with reduced baloxavir marboxil susceptibility after treatment of children with influenza A during the 2018/2019 influenza season.
J Infect Dis. 2020 Feb 8. pii: 5730526. doi: 10.1093.
PubMed Abstract available

FUENTES S, Hahn M, Chilcote K, Chemaly RF, et al
Antigenic Fingerprinting of Respiratory Syncytial Virus (RSV)-A-Infected Hematopoietic Cell Transplant Recipients Reveals Importance of Mucosal Anti-RSV G Antibodies in Control of RSV Infection in Humans.
J Infect Dis. 2020;221:636-646.
PubMed Abstract available

MCFARLAND EJ, Karron RA, Muresan P, Cunningham CK, et al
Live-attenuated respiratory syncytial virus vaccine with M2-2 deletion and with SH non-coding region is highly immunogenic in children.
J Infect Dis. 2020 Feb 1. pii: 5719572. doi: 10.1093.
PubMed Abstract available

January 2020

GUBAREVA LV, Fry AM
Baloxavir and Treatment-Emergent Resistance: Public Health Insights and Next Steps.
J Infect Dis. 2020;221:337-339.
PubMed

MONTO AS
Effectiveness of the Neuraminidase Inhibitors: The Supporting Evidence Increases.
J Infect Dis. 2020;221:340-342.
PubMed

BOONYARATANAKORNKIT J, Vivek M, Xie H, Pergam SA, et al
Predictive Value of Respiratory Viral Detection in the Upper Respiratory Tract for Infection of the Lower Respiratory Tract With Hematopoietic Stem Cell Transplantation.
J Infect Dis. 2020;221:379-388.
PubMed Abstract available

December 2019

DAWOOD FS, Garg S, Fink RV, Russell ML, et al
Epidemiology and clinical outcomes of hospitalizations for acute respiratory or febrile illness and laboratory-confirmed influenza among pregnant women during six influenza seasons, 2010-2016.
J Infect Dis. 2019 Dec 26. pii: 5687022. doi: 10.1093.
PubMed Abstract available

SHI N, Huang J, Zhang X, Bao C, et al
Corrigendum to: Interventions in Live Poultry Markets for the Control of Avian Influenza: A Systematic Review and Meta-analysis.
J Infect Dis. 2019 Dec 20. pii: 5682401. doi: 10.1093.
PubMed

KISO M, Yamayoshi S, Murakami J, Kawaoka Y, et al
Baloxavir marboxil treatment of nude mice infected with influenza A virus.
J Infect Dis. 2019 Dec 14. pii: 5677533. doi: 10.1093.
PubMed Abstract available

WANG Y, Fan G, Salam A, Horby P, et al
Comparative effectiveness of combined favipiravir and oseltamivir therapy versus oseltamivir monotherapy in critically ill patients with influenza virus infection.
J Infect Dis. 2019 Dec 11. pii: 5673088. doi: 10.1093.
PubMed Abstract available

November 2019

SCHUIT M, Gardner S, Wood S, Bower K, et al
The Influence of Simulated Sunlight on the Inactivation of Influenza Virus in Aerosols.
J Infect Dis. 2019 Nov 28. pii: 5645407. doi: 10.1093.
PubMed Abstract available

TENG MN, Mejias A, Ramilo O, Peeples ME, et al
Live Attenuated Vaccine with a Stabilized Mutation and Gene Deletion for Prevention of Respiratory Syncytial Virus Disease in Young Children.
J Infect Dis. 2019 Nov 23. pii: 5638037. doi: 10.1093.
PubMed

MCFARLAND EJ, Karron RA, Muresan P, Cunningham CK, et al
Live respiratory syncytial virus attenuated by M2-2 deletion and stabilized temperature sensitivity mutation 1030s is a promising vaccine candidate in children.
J Infect Dis. 2019 Nov 23. pii: 5638036. doi: 10.1093.
PubMed Abstract available

KEITEL WA, Atmar RL
Corrigendum to : Influenza Vaccines After 7 Decades: Still on the Learning Curve.
J Infect Dis. 2019 Nov 20. pii: 5634378. doi: 10.1093.
PubMed

WALKER JL, Zhao H, Dabrera G, Andrews N, et al
Assessment of Effectiveness of Seasonal Influenza Vaccination During Pregnancy in Preventing Influenza Infection in Infants in England, 2013-2014 and 2014-2015.
J Infect Dis. 2019 Nov 9. pii: 5618766. doi: 10.1093.
PubMed Abstract available

LEE HS, Noh JY, Shin OS, Song JY, et al
Matrix metalloproteinase-13 in atherosclerotic plaque is increased by influenza A virus infection.
J Infect Dis. 2019 Nov 6. pii: 5613981. doi: 10.1093.
PubMed Abstract available

WALKER TA, Waite B, Thompson MG, McArthur C, et al
Risk of Severe Influenza among Adults with Chronic Medical Conditions.
J Infect Dis. 2019 Nov 4. pii: 5611323. doi: 10.1093.
PubMed Abstract available

October 2019

COHEN C, Nunes MC
Vaccinating Mothers to Protect Their Babies Against Influenza.
J Infect Dis. 2019 Oct 31. pii: 5610713. doi: 10.1093.
PubMed

FLANNERY B, Kondor RJG, Chung JR, Gaglani M, et al
Spread of antigenically drifted influenza A(H3N2) viruses and vaccine effectiveness in the United States during the 2018-2019 season.
J Infect Dis. 2019 Oct 30. pii: 5609441. doi: 10.1093.
PubMed Abstract available

ATMAR RL, Keitel WA
Searching for Improved Flu Vaccines - The Time Is Now.
J Infect Dis. 2019 Oct 30. pii: 5609442. doi: 10.1093.
PubMed

MARTINEZ L, Cheng W, Wang X, Ling F, et al
A Risk Classification Model to Predict Mortality Among Laboratory-Confirmed Avian Influenza A H7N9 Patients: A Population-Based Observational Cohort Study.
J Infect Dis. 2019 Oct 17. pii: 5589175. doi: 10.1093.
PubMed Abstract available

LU Y, Chillarige Y, Izurieta HS, Wei Y, et al
Erratum to: Effect of Age on Relative Effectiveness of High-Dose Versus Standard-Dose Influenza Vaccines Among US Medicare Beneficiaries Aged >/=65 Years.
J Infect Dis. 2019 Oct 17. pii: 5588808. doi: 10.1093.
PubMed

KARRON RA, Luongo C, Mateo JS, Wanionek K, et al
Safety and Immunogenicity of the Respiratory Syncytial Virus Vaccine RSV/DeltaNS2/Delta1313/I1314L in RSV-Seronegative Children.
J Infect Dis. 2019 Oct 12. pii: 5586371. doi: 10.1093.
PubMed Abstract available

PARK YH, Chungu K, Lee SB, Woo SJ, et al
Host-specific restriction of avian influenza virus caused by differential dynamics of ANP32 family members.
J Infect Dis. 2019 Oct 3. pii: 5580703. doi: 10.1093.
PubMed Abstract available

September 2019

L'HUILLIER AG, Ferreira VH, Hirzel C, Natori Y, et al
Cell-Mediated Immune Responses after Influenza Vaccination of Solid Organ Transplant Recipients: a Secondary Outcomes Analysis of a Randomized Controlled Trial.
J Infect Dis. 2019 Sep 24. pii: 5573328. doi: 10.1093.
PubMed Abstract available

GERSHON AS, Chung H, Porter J, Campitelli MA, et al
Influenza Vaccine Effectiveness in Preventing Hospitalizations in Older Patients With Chronic Obstructive Pulmonary Disease.
J Infect Dis. 2019 Sep 24. pii: 5573043. doi: 10.1093.
PubMed Abstract available

RAMILO O, Rodriguez-Fernandez R, Peeples ME, Mejias A, et al
Advanced Live Attenuated Vaccines for the Prevention of Respiratory Syncytial Virus Infections in Young Children.
J Infect Dis. 2019 Sep 24. pii: 5573046. doi: 10.1093.
PubMed

CHESNOKOV A, Patel MC, Mishin VP, De La Cruz JA, et al
Replicative fitness of seasonal influenza A viruses with decreased susceptibility to baloxavir.
J Infect Dis. 2019 Sep 21. pii: 5572441. doi: 10.1093.
PubMed Abstract available

August 2019

SCHWARZ TF, McPhee RA, Launay O, Leroux-Roels G, et al
Immunogenicity and safety of 3 formulations of a respiratory syncytial virus candidate vaccine in non-pregnant women: a phase II, randomized trial.
J Infect Dis. 2019 Aug 16. pii: 5550410. doi: 10.1093.
PubMed Abstract available

MUNOZ FM, Swamy GK, Hickman SP, Agrawal S, et al
Safety and Immunogenicity of a Respiratory Syncytial Virus Fusion (F) Protein Nanoparticle Vaccine in Healthy Third-Trimester Pregnant Women and Their Infants.
J Infect Dis. 2019 Aug 12. pii: 5546089. doi: 10.1093.
PubMed Abstract available

June 2019

GERN JE, Lee WM, Swenson CA, Nakagome K, et al
Development of a Rhinovirus Inoculum Using a Reverse Genetics Approach.
J Infect Dis. 2019;220:187-194.
PubMed Abstract available

PROUD D
Reverse Genetics and Rhinovirus-A New Approach to an Old Problem?
J Infect Dis. 2019;220:181-183.
PubMed

POLACK FP, Stein RT, Custovic A
The Syndrome We Agreed to Call Bronchiolitis.
J Infect Dis. 2019;220:184-186.
PubMed Abstract available

May 2019

CILLONIZ C, Dominedo C, Magdaleno D, Ferrer M, et al
Pure viral sepsis secondary to Community-Acquired Pneumonia in adults: risk and prognostic factors.
J Infect Dis. 2019 May 21. pii: 5494607. doi: 10.1093.
PubMed Abstract available

MANSBACH JM, Hasegawa K, Piedra PA, Avadhanula V, et al
Haemophilus-Dominant Nasopharyngeal Microbiota Is Associated With Delayed Clearance of Respiratory Syncytial Virus in Infants Hospitalized for Bronchiolitis.
J Infect Dis. 2019;219:1804-1808.
PubMed Abstract available

April 2019

GARCIA-MAURINO C, Moore-Clingenpeel M, Thomas J, Mertz S, et al
Viral Load Dynamics and Clinical Disease Severity in Infants With Respiratory Syncytial Virus Infection.
J Infect Dis. 2019;219:1207-1215.
PubMed Abstract available

YU J, Peterson DR, Baran AM, Bhattacharya S, et al
Host Gene Expression in Nose and Blood for the Diagnosis of Viral Respiratory Infection.
J Infect Dis. 2019;219:1151-1161.
PubMed Abstract available

March 2019

KAMAU E, Onyango CO, Otieno GP, Kiyuka PK, et al
An Intensive, Active Surveillance Reveals Continuous Invasion and High Diversity of Rhinovirus in Households.
J Infect Dis. 2019;219:1049-1057.
PubMed Abstract available

February 2019

VAN ERP EA, Feyaerts D, Duijst M, Mulder HL, et al
Respiratory Syncytial Virus Infects Primary Neonatal and Adult Natural Killer Cells and Affects Their Antiviral Effector Function.
J Infect Dis. 2019;219:723-733.
PubMed Abstract available

January 2019

KANEKIYO M, Ellis D, King NP
New Vaccine Design and Delivery Technologies.
J Infect Dis. 2019 Jan 31. pii: 5304933. doi: 10.1093.
PubMed Abstract available

ANDERSON LJ, Peret TC, Piedra PA
RSV Strains and Disease Severity.
J Infect Dis. 2019;219:514-516.
PubMed

MIDULLA F, Nenna R, Scagnolari C, Petrarca L, et al
How Respiratory Syncytial Virus Genotypes Influence the Clinical Course in Infants Hospitalized for Bronchiolitis.
J Infect Dis. 2019;219:526-534.
PubMed Abstract available

CABALLERO MT, Bianchi AM, Nuno A, Ferretti AJP, et al
Mortality Associated With Acute Respiratory Infections Among Children at Home.
J Infect Dis. 2019;219:358-364.
PubMed Abstract available

FURUSE Y, Tamaki R, Okamoto M, Saito-Obata M, et al
Association Between Preceding Viral Respiratory Infection and Subsequent Respiratory Illnesses Among Children: A Prospective Cohort Study in the Philippines.
J Infect Dis. 2019;219:197-205.
PubMed Abstract available

MAZUR NI, Horsley NM, Englund JA, Nederend M, et al
Breast Milk Prefusion F Immunoglobulin G as a Correlate of Protection Against Respiratory Syncytial Virus Acute Respiratory Illness.
J Infect Dis. 2019;219:59-67.
PubMed Abstract available

December 2018

HELLFERSCEE O, Treurnicht FK, Walaza S, du Plessis M, et al
The fraction of rhinovirus detections attributable to mild and severe respiratory illness in a high HIV-prevalence setting, South Africa, 2013-2015.
J Infect Dis. 2018 Dec 22. pii: 5257995. doi: 10.1093.
PubMed Abstract available

July 2018

NING T, Nie J, Huang W, Li C, et al
Antigenic Drift of H7N9 Viral Hemagglutinin.
J Infect Dis. 2018 Jul 5. pii: 5049177. doi: 10.1093.
PubMed Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Influenza is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: